TruBridge (TBRG) 10-K 15 Mar 22 2021 FY Annual report Financial data

Cover page

Cover page - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 14, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	000-49796
Entity Registrant Name	COMPUTER PROGRAMS AND SYSTEMS, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	74-3032373
Entity Address, Address Line One	54 St. Emanuel Street
Entity Address, City or Town	Mobile
Entity Address, State or Province	AL
Entity Address, Postal Zip Code	36602
City Area Code	251
Local Phone Number	639-8100
Title of 12(b) Security	Common Stock, par value $.001 per share
Trading Symbol	CPSI
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 407,759,614
Entity Common Stock, Shares Outstanding		14,621,905
Documents Incorporated by Reference	Portions of the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this report to the extent described herein.
Entity Central Index Key	0001169445
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Firm ID	248
Auditor Name	GRANT THORNTON LLP
Auditor Location	Atlanta, Georgia

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 11,431	$ 12,671
Accounts receivable, net of allowance for credit losses of $1,826 and $1,701, respectively	34,431	32,414
Financing receivables, current portion, net	6,488	10,821
Inventories	855	1,084
Prepaid income taxes	4,599	1,789
Prepaid expenses and other	11,194	8,365
Total current assets	68,998	67,144
Property and equipment, net	11,590	13,139
Software development costs, net	11,644	3,210
Operating lease assets	7,097	6,610
Financing receivables, net of current portion	7,231	11,477
Other assets, net of current portion	3,874	2,787
Intangible assets, net	95,203	71,689
Goodwill	177,713	150,216
Total assets	383,350	326,272
Current liabilities:
Accounts payable	8,079	7,716
Current portion of long-term debt	4,394	3,457
Deferred revenue	11,529	8,130
Accrued vacation	5,262	5,353
Other accrued liabilities	17,163	12,786
Total current liabilities	46,427	37,442
Long-term debt, net of current portion	94,966	73,360
Operating lease liabilities, net of current portion	5,505	5,092
Deferred tax liabilities	13,880	10,378
Total liabilities	160,778	126,272
Stockholders’ equity:
Common stock, $0.001 par value per share; 30,000 shares authorized; 14,734 shares issued at December 31, 2021 and 14,511 shares issued at December 31, 2020	15	15
Additional paid-in capital	187,079	181,622
Retained earnings	38,054	19,624
Treasury stock, 89 shares at December 31, 2021 and 47 shares at December 31, 2020	(2,576)	(1,261)
Total stockholders’ equity	222,572	200,000
Total liabilities and stockholders’ equity	$ 383,350	$ 326,272

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,826	$ 1,701
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	30,000	30,000
Common stock, shares issued (in shares)	14,734	14,511
Common stock, shares outstanding (in shares)	14,734	14,511
Treasury stock, shares (in shares)	89	47

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Sales revenues:
Sales revenues:	$ 280,629	$ 264,488	$ 274,634
Costs of sales (exclusive of amortization shown separately below):
Total costs of sales	139,747	128,242	130,489
Gross profit	140,882	136,246	144,145
Operating expenses:
Product development	30,389	33,457	36,861
Sales and marketing	21,978	22,835	26,495
General and administrative	50,022	47,479	45,200
Amortization of acquisition-related intangibles	13,786	11,421	11,006
Total operating expenses	116,175	115,192	119,562
Operating income	24,707	21,054	24,583
Other income (expense):
Other income	1,529	1,494	807
Gain on contingent consideration	0	0	5,000
Loss on extinguishment of debt	0	(202)	0
Interest expense	(3,160)	(3,562)	(6,694)
Total other income (expense)	(1,631)	(2,270)	(887)
Income before taxes	23,076	18,784	23,696
Provision for income taxes	4,646	4,538	3,228
Net income	$ 18,430	$ 14,246	$ 20,468
Net income (loss) per share - basic (in dollars per share)	$ 1.26	$ 0.98	$ 1.43
Net income (loss) per share - diluted (in dollars per share)	$ 1.26	$ 0.98	$ 1.43
Weighted average shares outstanding used in per common share computations:
Basic (in shares)	14,290	14,038	13,778
Diluted (in shares)	14,318	14,038	13,778
System sales and support
Sales revenues:
Sales revenues:	$ 143,109	$ 152,954	$ 165,352
Costs of sales (exclusive of amortization shown separately below):
Total costs of sales	70,664	69,361	73,872
TruBridge
Sales revenues:
Sales revenues:	137,520	111,534	109,282
Costs of sales (exclusive of amortization shown separately below):
Total costs of sales	$ 69,083	$ 58,881	$ 56,617

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2018		14,083
Beginning balance at Dec. 31, 2018	$ 159,783	$ 14	$ 164,793	$ (5,024)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,468			20,468
Common stock issued upon exercise of stock options (in shares)		1
Common stock issued upon exercise of stock options	3		3
Issuance of restricted stock (in shares)		272
Stock-based compensation	9,822		9,822
Dividends	(5,729)			(5,729)
Ending balance (in shares) at Dec. 31, 2019		14,356
Ending balance at Dec. 31, 2019	184,347	$ 14	174,618	9,715	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	14,246			14,246
Issuance of restricted stock (in shares)		156
Issuance of restricted stock		$ 1	(1)
Forfeiture of common stock (in shares)		(1)
Stock-based compensation	7,005		7,005
Treasury stock purchases	(1,261)				(1,261)
Dividends	(4,337)			(4,337)
Ending balance (in shares) at Dec. 31, 2020		14,511
Ending balance at Dec. 31, 2020	200,000	$ 15	181,622	19,624	(1,261)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	18,430			18,430
Issuance of restricted stock (in shares)		229
Forfeiture of common stock (in shares)		(6)
Stock-based compensation	5,457		5,457
Treasury stock purchases	(1,315)				(1,315)
Ending balance (in shares) at Dec. 31, 2021		14,734
Ending balance at Dec. 31, 2021	$ 222,572	$ 15	$ 187,079	$ 38,054	$ (2,576)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating Activities
Net income (loss)	$ 18,430	$ 14,246	$ 20,468
Adjustments to net income:
Provision for bad debt	2,592	4,370	2,348
Deferred taxes	3,502	2,755	1,011
Stock based compensation	5,457	7,005	9,822
Depreciation	2,156	1,790	1,407
Amortization of acquisition-related intangibles	13,786	11,421	11,006
Amortization of software development costs	931	118	0
Amortization of deferred finance costs	293	317	345
Gain on contingent consideration	0	0	(5,000)
Loss on extinguishment of debt	0	202	0
Loss on disposal of property and equipment	313	0	0
Changes in operating assets and liabilities (net of acquired assets and liabilities):
Accounts receivable	(3,204)	3,667	641
Financing receivables	8,098	6,369	3,053
Inventories	229	342	72
Prepaid expenses and other	(3,914)	(3,519)	(1,474)
Accounts payable	(615)	(1,088)	2,542
Deferred revenue	2,099	(498)	(2,003)
Other liabilities	401	2,097	(1,418)
Prepaid income taxes/income taxes payable	(2,810)	(452)	782
Net cash provided by operating activities	47,744	49,142	43,602
Investing Activities
Purchases of property and equipment	(920)	(3,336)	(1,760)
Purchase of business, net of cash received	(59,634)	0	(10,733)
Investment in software development	(9,365)	(3,328)	0
Net cash used in investing activities	(69,919)	(6,664)	(12,493)
Financing Activities
Dividends paid	0	(4,337)	(5,729)
Proceeds from long-term debt	0	64	0
Payments of long-term debt principal	(3,750)	(4,069)	(13,609)
Proceeds from revolving line of credit	61,000	0	11,000
Payments of revolving line of credit	(35,000)	(27,561)	(20,693)
Payments on capital lease	0	0	(250)
Payments of contingent consideration	0	0	(206)
Proceeds from exercise of stock options	0	0	3
Treasury stock purchases	(1,315)	(1,261)	0
Net cash provided by (used in) financing activities	20,935	(37,164)	(29,484)
Increase (decrease) in cash and cash equivalents	(1,240)	5,314	1,625
Cash and cash equivalents at beginning of year	12,671	7,357	5,732
Cash and cash equivalents at end of year	11,431	12,671	7,357
Supplemental disclosure of cash flow information:
Cash paid for interest	2,817	3,245	6,342
Cash paid for income taxes, net of refund	3,503	2,235	3,193
Supplemental disclosure of non-cash flow information:
Write-off of fully depreciated assets	$ 0	$ 1,618	$ 0

Nature of Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	NATURE OF OPERATIONSComputer Programs and Systems, Inc. ("CPSI" or the "Company") is a healthcare information technology solutions provider which was formed and commenced operations in 1979. The Company provides, on an integrated basis, enterprise-wide clinical management, access management, patient financial management, health information management, strategic decision support, resource planning management and enterprise application integration solutions to healthcare organizations throughout the United States. Additionally, CPSI provides other information technology solutions, including business management services, remote hosting, networking technologies and other related services.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The consolidated financial statements of CPSI include the accounts of TruBridge, LLC ("TruBridge"), Evident, LLC ("Evident"), iNetXperts, Corp. d/b/a Get Real Health ("Get Real Health"), Healthland Holding Inc. ("HHI"), and TruCode, LLC ("TruCode"), all of which are wholly-owned subsidiaries of CPSI. The accounts of HHI include those of its wholly-owned subsidiaries, Healthland Inc. ("Healthland"), Rycan Technologies, Inc. ("Rycan"), and American HealthTech, Inc. ("AHT"). All significant intercompany balances and transactions have been eliminated. Cash and Cash Equivalents Cash and cash equivalents can include time deposits and certificates of deposit with original maturities of three months or less that are highly liquid and readily convertible to a known amount of cash. These assets are stated at cost, which approximates market value, due to their short duration or liquid nature. Change in Useful Lives of Intangible Assets In accordance with its policy, the Company reviews the estimated useful lives of its intangible assets on an ongoing basis. This review indicated that the actual lives of certain developed technology were shorter than the estimated useful lives used for amortization purposes in the Company's financial statements. As a result, effective January 1, 2021, the Company changed its estimates of the useful lives of certain developed technology to better reflect the estimated periods during which these assets will remain in service. The remaining useful life of certain developed technology that was 3.25 years at January 1, 2021 was reduced to 2 years, while the remaining useful life of certain developed technology that was 4.25 years was reduced to 3 years. The effect of this change was to increase 2021 amortization expense by approximately $1.0 million and decrease 2021 net income and basic and diluted earnings per share by $0.8 million and $0.06, respectively. Presentation Effective January 1, 2021, costs associated with our internal legal, compliance, and contract administration activities, which were formerly included within the caption “Sales and marketing” on our consolidated statements of operations, have been recorded as a component of “General and administrative” expenses. Amounts presented for the years ended December 31, 2020 and 2019, have been reclassified to conform to the current presentation. The following table provides the amount reclassified for the year ended December 31, 2020: (in thousands) As previously reported Re-classifications As reclassified Operating expenses Sales and marketing $ 24,185 $ (1,350) $ 22,835 General and administrative $ 46,129 $ 1,350 $ 47,479 The following table provides the amount reclassified for the year ended December 31, 2019: (in thousands) As previously reported Re-classifications As reclassified Operating expenses Sales and marketing $ 27,774 $ (1,279) $ 26,495 General and administrative $ 43,921 $ 1,279 $ 45,200 Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company establishes a general allowance for credit losses based on collections history. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific allowance for credit losses may be recorded to reduce the related receivable to the amount expected to be recovered. Financing Receivables Financing receivables are comprised of short-term payment plans and sales-type leases. Short-term payment plans are stated at the amount the Company expects to collect and do not bear interest. Sales-type leases are initially recorded at the present value of the related minimum lease payments. An allowance for credit losses has been established for our financing receivables based on the historical level of customer defaults under such arrangements. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific reserve may be recorded to reduce the related receivable to the amount expected to be recovered. Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms, with amounts reclassified to accounts receivable when they become due. As a result, we evaluate the credit quality of our financing receivables on an ongoing basis utilizing an aging of receivables and write-offs, customer collection experience, the customer’s financial condition and known risk characteristics impacting the respective customer base, as well as existing economic conditions, to determine if any further allowance is necessary. Amounts are specifically charged off once all available means of collection have been exhausted. Inventories Inventories are stated at lower of cost or net realizable value using the average cost method. The Company’s inventories are comprised of computer equipment, forms and supplies. Property and Equipment Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements to property and equipment that materially increase productive capacity or extend the life of an asset are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other disposition of such assets, the related costs and accumulated depreciation are removed from the respective accounts and any resulting gain or loss is included in the results of operations. Depreciation expense is computed using the straight-line method over the asset’s useful life, which is generally 5 years for computer equipment, furniture, and fixtures and 30 years for buildings. Leasehold improvements are depreciated over the shorter of the asset’s useful life or the remaining lease term. The Company reviews for the possible impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation expense is reported in the consolidated statements of operations as a component of costs of sales and operating expenses. Business Combinations We apply business combination accounting when we acquire a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded in general and administrative expenses; restructuring costs associated with a business combination are expenses; contingent consideration is measured at fair value at the acquisition date, with changes in fair value after the acquisition date affecting earnings; changes in deferred tax asset valuation allowances and income tax uncertainties after the measurement period affect income tax expense; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the Consolidated Statements of Operations of the combined entity beginning on the date of the acquisition. We have applied this acquisition method to the transactions described in Note 3 - Business Combination. Goodwill Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the identifiable net tangible and intangible assets acquired. Goodwill is not amortized but is evaluated for impairment annually or more frequently if indicators of impairment are present or changes in circumstances suggest that impairment may exist. We test annually for impairment as of October 1. As part of our annual goodwill impairment test, we first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we conduct a quantitative goodwill impairment assessment, which compares the fair value of the reporting unit with its carrying amount, including goodwill. If the carrying amount of the reporting unit exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the total amount of goodwill allocated to that reporting unit. If the fair value of the reporting unit exceeds its carrying amount, the goodwill of the reporting unit is not considered to be impaired. We determined there was no impairment to goodwill for the years ended December 31, 2021, 2020 and 2019. Purchased Intangible Assets Purchased intangible assets are acquired in connection with a business acquisition, and are amortized over their estimated useful lives based on the pattern of economic benefit expected from each asset. We concluded for certain purchased intangible assets that the pattern of economic benefit approximated the straight-line method, and therefore, the use of the straight-line method was appropriate, as the majority of the cash flows will be recognized ratably over the estimated useful lives and there is no degradation of the cash flows over time. We assess the recoverability of intangible assets whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The carrying amount is not recoverable if it exceeds the undiscounted sum of cash flows expected to result from the use and eventual disposition of the asset. If the asset is not recoverable, the impairment loss is measured by the excess of the asset's carrying amount over its fair value. We determined there was no impairment to purchased intangible assets as of December 31, 2021, 2020 or 2019. Revenue Recognition Revenue is recognized upon transfer of control of promised products or services to clients in an amount that reflects the consideration we expect to receive in exchange for those products and services. We enter into contracts that can include various combinations of products and services, which are generally distinct and accounted for as separate performance obligations. The Company employs the 5-step revenue recognition model under ASC 606, Revenue from Contracts with Customers, to: (1) identify the contract with the client, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue is recognized net of shipping charges and any taxes collected from clients, which are subsequently remitted to governmental authorities. • System Sales and Support The Company enters into contractual obligations to sell perpetual software licenses, installation, conversion, and related training services, software application support, hardware, and hardware maintenance services to acute care community hospitals and post-acute providers. • Non-recurring Revenues • Perpetual software licenses and installation, conversion, and related training services are not considered separate and distinct performance obligations due to the proprietary nature of our software and are, therefore, accounted for as a single performance obligation on a module-by-module basis. Revenue is recognized as each module's implementation is completed based on the module's stand-alone selling price ("SSP"), net of discounts. We determine each module's SSP using the residual method. Fees for licenses and installation, conversion, and related training services are typically due in three installments: (1) at placement of order, (2) upon installation of software and commencement of training, and (3) upon satisfactory completion of monthly accounting cycle or end-of-month operation by application and as applicable for each application. Often, short-term and/or long-term financing arrangements are provided for software implementations; refer to Note 11 - Financing Receivables for further information. Electronic health records ("EHR") implementations include a system warranty that terminates thirty days from the software go-live date, the date which the client begins using the system in a live environment. • Hardware revenue is recognized separately from software licenses at the point in time it is delivered to the client. The SSP of hardware is cost plus a reasonable margin and revenue is recognized on a gross basis. Payment is generally due upon delivery of the hardware to the client. Standard manufacturer warranties apply to hardware. • Recurring Revenues • Software application support and hardware maintenance services sold with software licenses and hardware are separate and distinct performance obligations. Revenue for support and maintenance services is recognized based on SSP, which is the renewal price, ratably over the life of the contract, which is generally three • Subscriptions to third-party content revenue is recognized as a separate performance obligation ratably over the subscription term based on SSP, which is cost plus a reasonable margin, and revenue is recognized on a gross basis. Payment is due monthly for subscriptions to third party content. • Software as a Service ("SaaS") arrangements for EHR software and related conversion and training services are considered a single performance obligation. Revenue is recognized on a monthly basis as the SaaS service is provided to the client over the contract term. Payment is due monthly for SaaS services provided. Refer to Note 18 - Segment Reporting for further information, including revenue by client base (acute care or post-acute care) bifurcated by recurring and non-recurring revenue. • TruBridge TruBridge provides an array of business processing services ("BPS") consisting of accounts receivable management, private pay services, insurance services, medical coding, electronic billing, statement processing, payroll processing, and contract management. Fees are recognized over the period of the client contractual relationship as the services are performed based on the SSP, net of discounts. SSP for TruBridge BPS services is determined based on observable stand-alone selling prices. Fees for many of these services are invoiced, and revenue recognized accordingly, based on the volume of transactions or a percentage of client accounts receivable collections. Payment is due monthly for BPS with certain amounts varying based on utilization and/or volumes. TruBridge also provides professional IT services. Revenue from professional IT services is recognized as the services are performed based on SSP, which is determined by observable stand-alone selling prices. Payment is due monthly as services are performed. Lastly, TruBridge also provides certain software solutions and related support under SaaS arrangements and time-based software licenses. Revenue from SaaS arrangements is recognized in a manner consistent with SaaS arrangements for EHR software, as discussed above. Revenue from time-based software licenses is recognized upon delivery to the client (“point in time”) and revenue from non-license components (i.e., support) is recognized ratably over the respective contract term (“over time”). SSP for time-based licenses is determined using the residual approach, while the non-license component is based on cost plus reasonable margin. • Deferred Revenue Deferred revenue represents amounts invoiced to clients for which the services under contract have not been completed and revenue has not been recognized, including annual renewals of certain software subscriptions and customer deposits for implementations to be performed at a later date. Revenue is recognized ratably over the life of the software subscriptions as services are provided and at the point-in-time when implementations have been completed. The following table details deferred revenue for the years ended December 31, 2021 and 2020, included in the consolidated balance sheets: For years ended December 31, (In thousands) 2021 2020 Beginning balance $ 8,130 $ 8,628 Deferred revenue recorded 23,393 18,507 Deferred revenue acquired 1,300 — Less deferred revenue recognized as revenue (21,294) (19,005) Ending balance $ 11,529 $ 8,130 The deferred revenue recorded for years ended December 31, 2021 and 2020 is comprised primarily of the annual renewals of certain software subscriptions billed during the first quarter of each year and deposits collected for future EHR installations. The deferred revenue acquired resulted from the May 2021 acquisition of TruCode. The deferred revenue recognized as revenue during the years ended December 31, 2021 and 2020 is comprised primarily of the periodic recognition of annual renewals that were deferred until earned and deposits for future EHR installations that were deferred until earned. • Costs to Obtain and Fulfill a Contract with a Customer Costs to obtain a contract include the commission costs related to SaaS arrangements, which are capitalized and amortized ratably over the expected life of the customer. As a practical expedient, we generally recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset would have been one year or less, with the exception of commissions generated from TruBridge sales. TruBridge commissions, which are paid up to twelve months in advance, are capitalized and amortized over the prepayment period. Costs to obtain a contract are expensed within sales and marketing expenses in the accompanying consolidated statements of operations. Contract fulfillment costs related to the implementation of SaaS arrangements are capitalized and amortized ratably over the expected life of the customer. Costs to fulfill contracts consist of the payroll costs for the implementation of SaaS arrangements, including time for training, conversion, and installation that is necessary for the software to be utilized. Contract fulfillment costs are expensed within the caption "System sales and support - Cost of sales" in the accompanying consolidated statements of operations. Costs to obtain and fulfill contracts related to SaaS arrangements are included within the "Prepaid expenses and other" and "Other assets, net of current portion" line items on our consolidated balance sheets. The following table details costs to obtain and fulfill contracts with customers for the years ended December 31, 2021 and 2020, included in the consolidated balance sheets: For years ended December 31, (In thousands) 2021 2020 Beginning balance $ 5,992 $ 4,439 Costs to obtain and fulfill contracts capitalized 7,256 6,974 Less costs to obtain and fulfill contracts recognized as expense (5,936) (5,421) Ending balance $ 7,312 $ 5,992 • Significant Judgments Our contracts with clients often include promises to transfer multiple products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Judgment is required to determine SSP for each distinct performance obligation. We use observable SSP for items that are sold on a stand-alone basis to similarly situated clients at unit prices within a sufficiently narrow range. For performance obligations that are sold to different clients for a broad range of amounts, or for performance obligations that are never sold on a stand-alone basis, the residual method in determining SSP is applied and requires significant judgment. Allocating the transaction price, including estimating SSP of promised goods and services for contracts with discounts or variable consideration, may require significant judgment. Due to the short time frame of the implementation cycle, discount allocation is immaterial as revenue is recognized net of discounts within the same reporting period. In scenarios where the Company enters into a contract that includes both a software license and BPS or other services that are charged based on volume of services rendered, the Company allocates variable amounts entirely to a distinct good or service. The terms of the variable payment relate specifically to the entity’s efforts to satisfy that performance obligation. Significant judgment is required in determining the expected life of a customer, which is the amortization period for costs to obtain and fulfill a contract that have been capitalized. The Company determined that the expected life of the customer is not materially different from the initial contract term based on the characteristics of the SaaS offering. • Remaining Performance Obligations Disclosures regarding remaining performance obligations are not considered material as the overwhelming majority of the Company's remaining performance obligations either (a) are related to contracts with an expected duration of one year or less, or (b) exhibit revenue recognition in the amount to which the Company has the right to invoice. Stock-Based Compensation The Company accounts for stock-based compensation according to the provisions of ASC 718, Compensation – Stock Compensation , which establishes accounting for stock-based awards exchanged for employee services. Accordingly, stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period. Software Development Costs Our software solutions are offered to our clients through both traditional perpetual licenses as well as SaaS delivery models. Development costs associated with the certain solutions offered exclusively through a SaaS model are accounted for in accordance with ASC 350-40, Internal Use Software . All other client solution development costs are accounted for in accordance with ASC 985-20, Costs of Software to be Sold, Leased, or Marketed . Under ASC 985-20, software development costs incurred in creating computer software solutions are expensed until technological feasibility has been established upon completion of a detailed program design or, in the absence of a detailed program design, upon completion of a product design and working model of the software product. Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently recorded at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on the current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution, which is estimated to be five years. Under ASC 350-40, software development costs related to preliminary project activities and post-implementation and maintenance activities are expensed as incurred. We capitalize direct costs related to application development activities that are probable to result in additional functionality. Capitalized costs are amortized on a straight-line basis over five years. We test for impairment whenever events or changes in circumstances that could impact recoverability occur. See Note 5 - Software Development for further information relating to our software development costs. Income Taxes We account for income taxes in accordance with ASC 740, Accounting for Income Taxes . Under this topic, deferred income taxes are determined utilizing the asset and liability approach. This method gives consideration to the future tax consequences associated with differences between financial accounting and tax bases of assets and liabilities. The effect on the deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We recognize interest and penalties accrued related to unrecognized tax benefits in the consolidated statements of operations as a component of the provision for income taxes. We also make a provision for uncertain income tax positions in accordance with the ASC 740, Accounting for Income Taxes . These provisions require that a tax position taken in a tax return be recognized in the financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon settlement. The topic also requires that changes in judgment that result in subsequent recognition, derecognition, or change in a measurement date of a tax position taken in a prior annual period (including any related interest and penalties) be recognized as a discrete item in the interim period in which the change occurs. Valuation allowances are recorded when, in the opinion of management, it is more likely than not that all or a portion of the deferred tax assets will not be realized. These valuation allowances can be impacted by changes in tax laws, changes to statutory tax rates, and future taxable income, and are based on our judgment, estimates, and assumptions. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported revenues and expenses during the reporting periods. Actual results could differ from those estimates. Segment Reporting Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, which we refer to as the CODM, or decision-making group in assessing performance and making decisions regarding resource allocation. The Company has prepared operating segment information based on the manner in which management disaggregates the Company's operations for making internal operating decisions. For more information, see Note 18 - Segment Reporting. New Accounting Standards Adopted in 2021 There were no new accounting standards required to be adopted in 2021 that would have a material impact on our consolidated financial statements. New Accounting Standards Yet to be Adopted We do not believe that any recently issued but not yet effective accounting standards, if adopted, would have a material impact on our consolidated financial statements.

Business Combination

Business Combination	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Business Combination	BUSINESS COMBINATION Acquisition of TruCode On May 12, 2021, we acquired all of the assets and liabilities of TruCode LLC, a Virginia limited liability company ("TruCode"), pursuant to a Stock Purchase Agreement dated May 12, 2021. Based in Alpharetta, Georgia, TruCode provides configurable, knowledge-based software that gives coders, clinical documentation improvement specialists and auditors the flexibility to code according to their knowledge, preferences and experience. The cloud-based medical coding solution is bundled with the TruBridge solutions and services to enhance revenue cycle performance for healthcare organizations of all sizes. Consideration for the acquisition included cash (net of cash of the acquired entity) of $59.6 million (inclusive of seller's transaction expenses), plus a contingent earnout payment of up to $15.0 million tied to TruCode's earnings before interest, tax, depreciation, and amortization ("EBITDA") (subject to certain pro-forma adjustments) for the twelve- month period concluding on the anniversary date of the acquisition. During 2021, we incurred approximately $0.9 million of pre-tax acquisition costs in connection with the acquisition of TruCode. Acquisition costs are included in general and administrative expenses in our consolidated statements of operations. Our acquisition of TruCode was treated as a purchase in accordance with ASC 805, Business Combinations , which requires allocation of the purchase price to the estimated fair values of assets and liabilities acquired in the transaction. Our allocation of the purchase price was based on management's judgment after evaluating several factors, including a preliminary valuation assessment. Final settlement is pending related to acquired working capital and certain amounts due to third parties which remain in ongoing negotiations. The allocation of the purchase price paid for TruCode was as follows: (In thousands) Purchase Price Allocation Acquired cash $ 4,249 Accounts receivable 924 Prepaid expenses 2 Intangible assets 37,300 Goodwill 27,497 Accounts payable and accrued liabilities (2,289) Contingent consideration (2,500) Deferred revenue (1,300) Net assets acquired $ 63,883 The intangible assets in the table above are being amortized on a straight-line basis over their estimated useful lives. The amortization is included in amortization of acquisition-related intangibles in our consolidated statements of operations. The fair value measurements of tangible and intangible assets and liabilities were based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy (see Note 17 - Fair Value). Level 3 inputs included, among others, discount rates that we estimated would be used by a market participant in valuing these assets and liabilities, projections of revenues and cash flows, client attrition rates and market comparables. Our consolidated statement of operations for the year ended December 31, 2021 includes revenues of approximately $7.1 million, and pre-tax income of approximately $3.2 million, attributed to the acquired business since the May 12, 2021 acquisition date. The following unaudited pro forma revenue, net income and earnings per share amounts for the years ended December 31, 2021 and 2020 give effect to the TruCode acquisition as if it had been completed on January 1, 2020. The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of what the operating results actually would have been during the periods presented had the TruCode acquisition been completed during the periods presented. In addition, the unaudited pro forma financial information does not purport to project future operating results. The pro forma information does not fully reflect: (1) any anticipated synergies (or costs to achieve synergies) or (2) the impact of non-recurring items directly related to the TruCode acquisition. Year Ended December 31, (In thousands, except per share data, unaudited) 2021 2020 Pro forma revenues $ 286,651 $ 275,641 Pro forma net income $ 20,635 $ 14,651 Pro forma diluted earnings per share $ 1.41 $ 1.01 Pro forma net income was calculated by adjusting the results for the applicable period to reflect (i) the additional amortization that would have been charged assuming the fair value adjustments to intangible assets had been applied on January 1, 2020 and (ii) adjustments to amortized revenue during fiscal 2021 and 2020 as a result of the acquisition date valuation of assumed deferred revenue. The pro forma results for each period also reflect the pro forma adjustment to interest expense as a result of utilizing revolver debt to finance the acquisition. Acquisition of Get Real Health On May 3, 2019, we acquired all of the assets and liabilities of iNetXperts, Corp., a Maryland corporation doing business as Get Real Health (“Get Real Health”), pursuant to a Stock Purchase Agreement dated April 23, 2019, as amended on May 2, 2019. Based in Rockville, Maryland, Get Real Health delivers technology solutions to improve patient outcomes and engagement strategies with care providers. Consideration for the acquisition included cash (net of cash of the acquired entity) of $10.8 million (inclusive of seller's transaction expenses), plus a contingent earnout payment of up to $14.0 million tied to Get Real Health's earnings before interest, tax, depreciation, and amortization ("EBITDA") (subject to certain pro-forma adjustments) for 2019. As of December 31, 2019, the $5.0 million contingent consideration estimated in determining the acquisition purchase price was fully reversed as Get Real Health's earnings did not achieve the required level for earnout payment. During 2019, we incurred approximately $0.6 million of pre-tax acquisition costs in connection with the acquisition of Get Real Health. Acquisition costs are included in general and administrative expenses in our consolidated statements of operations. Our acquisition of Get Real Health was treated as a purchase in accordance with ASC 805, Business Combinations , which requires allocation of the purchase price to the estimated fair values of assets and liabilities acquired in the transaction. Our allocation of the purchase price was based on management's judgment after evaluating several factors, including a valuation assessment. The allocation of the purchase price paid for Get Real Health was as follows: (In thousands) Purchase Price Allocation Acquired cash $ 159 Accounts receivable 364 Prepaid expenses 107 Property and equipment 365 Operating lease asset 1,285 Intangible assets 7,890 Goodwill 9,767 Accounts payable and accrued liabilities (594) Deferred taxes, net (1,736) Operating lease liability (1,285) Contingent consideration (5,000) Deferred revenue (430) Net assets acquired $ 10,892 The intangible assets in the table above are being amortized on a straight-line basis over their estimated useful lives. The amortization is included in amortization of acquisition-related intangibles in our consolidated statements of operations. The fair value measurements of tangible and intangible assets and liabilities were based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy (see Note 17 - Fair Value). Level 3 inputs included, among others, discount rates that we estimated would be used by a market participant in valuing these assets and liabilities, projections of revenues and cash flows, client attrition rates and market comparables.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment	PROPERTY AND EQUIPMENT Property and equipment were comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Land $ 2,848 $ 2,848 Buildings and improvements 8,269 8,242 Computer equipment 7,868 7,144 Leasehold improvements 783 1,283 Office furniture and fixtures 682 829 Automobiles 18 18 20,468 20,364 Less: accumulated depreciation (8,878) (7,225) Property and equipment, net $ 11,590 $ 13,139

Software Development

Software Development	12 Months Ended
	Dec. 31, 2021
Research and Development [Abstract]
Software Development	SOFTWARE DEVELOPMENT Software development costs are accounted for in accordance with ASC 350-40, Internal-Use Software . We capitalize incurred labor costs for software development from the time the preliminary project phase is completed until the software is available for general release. Research and development costs and other computer software maintenance costs related to software development are expensed as incurred. We estimate the useful life of our capitalized software and amortize its value on a straight-line basis over that estimated life, which is estimated to be five years. If the actual life of the asset is deemed to be impaired, a write-down of the value of the asset may be recorded as a charge to earnings. Amortization begins when the related features are placed in service. During the second quarter of 2021, our ongoing monitoring activities associated with the capitalization of software development costs and the related correlation between capitalization rates and operational metrics designed to reflect the distribution of work revealed that our then-current labor capitalization methodology did not fully reflect all of the critical activities necessary to develop software assets. Consequently, during the second quarter of 2021, we elected to change our method of estimating the labor costs incurred in developing software assets. Prior to this change, we estimated the associated labor costs using an estimated time-equivalent for workload metrics commonly utilized within agile software development environments. With this change, we now estimate these labor costs using the distribution of these agile workload metrics between capitalizable and non-capitalizable units of work. We believe this change is preferable as the new methodology better estimates capitalizable labor costs and is consistent with industry best practices. We have determined that this change in accounting for software development costs is a change in accounting estimate effected by a change in accounting principle and, as such, has been accounted for on a prospective basis. In connection with this change, we capitalized software development costs of $8.8 million during the year ended December 31, 2021. We estimate that the effect of this change was to increase capitalized amounts by approximately $4.6 million for the year ended December 31, 2021, with a corresponding decrease to product development costs. Software development, net was comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Software development costs $ 12,693 $ 3,328 Less: accumulated amortization (1,049) (118) Software development costs, net $ 11,644 $ 3,210

Other Accrued Liabilities

Other Accrued Liabilities	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Other Accrued Liabilities	OTHER ACCRUED LIABILITIES Other accrued liabilities were comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Salaries and benefits $ 8,482 $ 7,876 Severance 236 25 Commissions 1,158 1,040 Self-insurance reserves 1,409 1,776 Contingent consideration 2,500 — Other 1,786 551 Operating lease liabilities, current portion 1,592 1,518 Other accrued liabilities $ 17,163 $ 12,786

Net Income Per Share

Net Income Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Net Income Per Share	NET INCOME PER SHARE The Company presents basic and diluted earnings per share ("EPS") data for its common stock. Basic EPS is calculated by dividing the net income attributable to stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all dilutive potential common shares, including awards under stock-based compensation arrangements. The Company's unvested restricted stock awards (see Note 9) are considered participating securities under ASC 260, Earnings Per Share , because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited. When a company has a security that qualifies as a "participating security," the Codification requires the use of the two-class method when computing basic EPS. The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net income to allocate to common stockholders, income is allocated to both common stock and participating securities based on their respective weighted average shares outstanding for the period, with net income attributable to common stockholders ultimately equaling net income less net income attributable to participating securities. Diluted EPS for the Company's common stock is computed using the more dilutive of the two-class method or the treasury stock method. The following is a calculation of the basic and diluted EPS for the Company's common stock, including a reconciliation between net income and net income attributable to common stockholders for the years ended December 31, 2021, 2020, and 2019: (In thousands, except for per share data) 2021 2020 2019 Basic EPS Numerator Net income $ 18,430 $ 14,246 $ 20,468 Less: Net income attributable to participating securities (409) (429) (764) Net income attributable to common stockholders $ 18,021 $ 13,817 $ 19,704 Denominator Weighted average shares outstanding used in basic per common share computations 14,290 14,038 13,778 Basic EPS $ 1.26 $ 0.98 $ 1.43 Diluted EPS Numerator Net income attributable to common stockholders for diluted EPS $ 18,021 $ 13,817 $ 19,704 Denominator Weighted average shares outstanding used in basic per common share computations 14,290 14,038 13,778 Weighted average effect of dilutive securities: Performance share awards 28 — — Weighted average shares outstanding used in diluted per common share computations 14,318 14,038 13,778 Diluted EPS $ 1.26 $ 0.98 $ 1.43

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes . These provisions require a company to determine whether it is more likely than not that a tax position will be sustained upon examination based on the technical merits of the position. If the more-likely-than-not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements. The Company did not have any unrecognized tax positions as of December 31, 2021 and 2020. The federal returns for tax years 2018 through 2020 remain open to examination, and the tax years 2017 through 2020 remain open to examination by certain other taxing jurisdictions to which the Company is subject. Additional years may be open to the extent attributes are being carried forward to an open year. Deferred income taxes arise from the temporary differences in the recognition of income and expenses for tax purposes. A valuation allowance is established when the Company believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Deferred tax assets and liabilities were comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Deferred tax assets: Accounts receivable and financing receivables $ 625 $ 773 Accrued vacation 678 691 Stock-based compensation 1,905 2,568 Deferred revenue 988 283 Accrued severance 44 4 Accrued liabilities 15 — Right of use asset 1,740 — Credits 2,472 3,274 Net operating loss 3,560 4,301 Deferred tax assets 12,027 11,894 Less: Valuation allowance 622 636 Total deferred tax assets $ 11,405 $ 11,258 Deferred tax liabilities: Intangible assets $ 18,002 $ 19,603 Accrued liabilities and other 4,668 956 Fixed assets 875 1077 Right of use liability $ 1,740 $ — Total deferred tax liabilities $ 25,285 $ 21,636 Total net deferred tax liability $ (13,880) $ (10,378) Significant components of the income tax provision for the years ended December 31, 2021, 2020 and 2019 were as follows: (In thousands) 2021 2020 2019 Current provision: Federal $ 731 $ 244 $ 860 State 413 1,539 1,357 Deferred provision: Federal 3,331 2,766 951 State 171 (11) 60 Total income tax provision $ 4,646 $ 4,538 $ 3,228 The difference between income taxes at the U.S. federal statutory income tax rate of 21% for the years ended December 31, 2021, 2020 and 2019, and those reported in the consolidated statements of operations for the years ended December 31, 2021, 2020 and 2019 are as follows: (In thousands) 2021 2020 2019 Income taxes at U.S. federal statutory rate $ 4,846 $ 3,945 $ 4,976 Provision-to-return adjustments 117 455 (66) State income tax, net of federal tax effect 509 908 978 Tax credits (1,274) (958) (2,196) Contingent consideration — — (1,050) Stock-based compensation (74) 255 151 Change in valuation allowance (14) (165) 173 Non-deductible compensation - 162(m) 510 — — Other 26 98 262 Total income tax provision $ 4,646 $ 4,538 $ 3,228 Our effective tax rates for the years ended December 31, 2021, 2020 and 2019 were 20%, 24% and 14% respectively. Our effective tax rate for 2019 was significantly impacted by the non-taxable nature of our recorded gain on contingent consideration, which served to reduce the year's effective tax rate by over 4%. 2020 lacked any benefit to the effective tax rate from such contingent consideration and, when combined with more punitive provision to return adjustments primarily related to R&D tax credits and lowered estimates for qualifying research expenditures during the year, thereby lowering estimates for the 2020 R&D tax credit, resulted in a significant increase in the effective tax rate for 2020. Lowered provision to return adjustments resulted in an incremental 2.6% decrease in our effective tax rate for 2021 compared to 2020, while decreased tax shortfalls related to stock-based compensation arrangements resulted in an incremental 1.9% decrease in our effective tax rate for 2021 compared to 2020. We have federal net operating loss carryforwards related to the acquisition of HHI and Get Real Health of $7.9 million, $12.2 million and $27.9 million for the years ending December 31, 2021, 2020, and 2019, respectively, which expire at various dates from 2026 to 2035. We have state net operating loss carryforwards related to the acquisition of HHI and Get Real Health of $29.9 million, $34.4 million and $34.5 million for the years ending December 31, 2021, 2020, and 2019, respectively, which expire at various dates from 2023 to 2036.

Stock-Based Compensation and Eq

Stock-Based Compensation and Equity	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation and Equity	STOCK-BASED COMPENSATION AND EQUITY The Company's stock-based compensation awards are in the form of restricted stock and performance share awards granted pursuant to the Company's 2012 Restricted Stock Plan for Non-Employee Directors, Amended and Restated 2014 Incentive Plan and 2019 Incentive Plan, as amended (the "Plans"). Stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period. As of December 31, 2021, there was a total o f 334,629 sh ar es of common stock reserved under the Plans for issuance under future share-based payment arrangements. The following table details total stock-based compensation expense for the years ended December 31, 2021, 2020 and 2019, included in the consolidated statements of operations: (In thousands) 2021 2020 2019 Costs of sales $ 990 $ 1,474 $ 2,040 Operating expenses 4,467 5,531 7,782 Pre-tax stock-based compensation expense 5,457 7,005 9,822 Less: income tax effect (1,146) (1,471) (2,063) Net (after tax) stock-based compensation expense $ 4,311 $ 5,534 $ 7,759 As of December 31, 2021, there was $7.0 million of unrecognized compensation cost related to unvested or unearned, as applicable, stock-based compensation arrangements granted under the Plans, which is expected to be recognized over a weighted-average period of 1.9 years. Restricted Stock The Company grants restricted stock to executive officers, certain key employees and non-employee directors under the 2019 Incentive Plan with the fair value of the awards representing the fair value of the common stock on the date the restricted stock is granted. Shares of restricted stock generally vest in equal annual installments over the applicable vesting period, which ranges from one Although no such one-year performance share awards were granted during 2021, shares issued pursuant to past one-year performance share awards are still subject to vesting. A summary of restricted stock activity (including shares of restricted stock issued pursuant to the settlement of performance share awards) under the Plans during the years ended December 31, 2021, 2020 and 2019 is as follows: Shares Weighted-Average Grant-Date Fair Value Unvested stock outstanding at January 1, 2019 475,132 $ 32.00 Granted 133,936 30.89 Performance share awards converted to restricted stock 138,566 29.80 Vested (221,775) 33.48 Unvested stock outstanding at December 31, 2019 525,859 $ 30.51 Granted 136,771 26.16 Performance share awards converted to restricted stock 19,678 30.15 Vested (268,067) 30.80 Forfeited (1,274) 26.16 Unvested stock outstanding at December 31, 2020 412,967 $ 28.87 Granted 153,700 31.22 Vested (245,455) 29.16 Forfeited (6,329) 29.10 Unvested stock outstanding at December 31, 2021 314,883 $ 29.79 Performance Share Awards The Company grants performance share awards to executive officers and certain key employees under the Amended and Restated 2014 Incentive Plan prior to 2019 and under the 2019 Incentive Plan beginning in 2019. The number of shares of common stock earned and issuable under each award is determined at the end of each one-year or three-year performance period, based on the Company's achievement of performance goals predetermined by the Compensation Committee of the Board of Directors at the time of grant. The three-year performance share awards include a modifier to the total number of shares earned based on the Company's total shareholder return ("TSR") compared to an industry index. If certain levels of the performance objective are met, the award results in the issuance of shares of restricted stock or common stock corresponding to such level. One-year performance share awards are then subject to time-based vesting pursuant to which the shares of restricted stock vest in equal annual installments over the applicable vesting period, which is generally three years. Three-year performance share awards result in the issuance of shares of common stock that are not subject to time-based vesting at the conclusion of the three-year performance period if earned. In the event that the Company's financial performance meets the predetermined targets for the performance objectives of the one-year or three-year performance share awards, the Company will issue each award recipient the number of shares of restricted stock or common stock, as applicable, equal to the target award specified in the individual's underlying performance share award agreement. In the event the financial results of the Company exceed the predetermined targets, additional shares up to the maximum award may be issued. In the event the financial results of the Company fall below the predetermined targets, a reduced number of shares may be issued. If the financial results of the Company fall below the threshold performance levels, no shares will be issued. The total number of shares issued for the three-year performance share award may be increased, decreased, or unchanged based on the TSR modifier described above. The recipients of performance share awards do not receive dividends or possess voting rights during the performance period and, accordingly, the fair value of the one-year performance share awards is the quoted market value of CPSI's common stock on the grant date less the present value of the expected dividends not received during the relevant period. The TSR modifier applicable to the three-year performance share awards is considered a market condition and therefore is reflected in the grant date fair value of the award. A Monte Carlo simulation has been used to account for this market condition in the grant date fair value of the award. Expense of one-year performance share awards is recognized using the accelerated attribution (graded vesting) method over the period beginning on the date the Company determines that it is probable that the performance criteria will be achieved and ending on the last day of the vesting period for the restricted stock issued in satisfaction of such awards. Expense of three-year performance share awards is recognized using ratable straight-line amortization over the three-year performance period. In the event the Company determines it is no longer probable that the minimum performance level will be achieved, all previously recognized compensation expense related to the applicable awards is reversed in the period such a determination is made. A summary of performance share award activity under the Plans for the years ended December 31, 2021, 2020 and 2019, is as follows, based on the target award amounts set forth in the performance share award agreements: Shares Weighted-Average Grant-Date Fair Value Performance share awards outstanding at January 1, 2019 184,776 $ 30.15 Granted 110,310 30.95 Forfeited or unearned 44,189 29.77 Performance share awards converted to restricted stock (138,566) 29.80 Performance share awards outstanding at December 31, 2019 200,709 $ 30.75 Granted 107,298 26.96 Forfeited or unearned (35,477) 30.15 Performance share awards converted to restricted stock (19,678) 30.15 Performance share awards outstanding at December 31, 2020 252,852 $ 29.27 Granted 93,444 31.26 Forfeited or unearned (20,373) 29.92 Vested and issued (75,971) 30.50 Performance share awards outstanding at December 31, 2021 249,952 $ 29.59 Stock Repurchases

Concentration of Credit Risk

Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	CONCENTRATION OF CREDIT RISK Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of temporary cash investments and trade receivables (including financing receivables). The Company places its temporary cash investments with credit-worthy, high-quality financial institutions. The Company’s customer base is concentrated in the healthcare industry. Customers are primarily located throughout the United States. The Company requires no collateral or other security to support customer trade receivables. An allowance for credit losses for trade receivables and an allowance for credit losses for financing receivables have been established for potential credit losses based on historical collection experience. The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents.

Financing Receivables

Financing Receivables	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Financing Receivables	FINANCING RECEIVABLES Short-Term Payment Plans The Company provides fixed monthly payment arrangements ("short-term payment plans") over terms ranging from three (In thousands) 2021 2020 Short-term payment plans, gross $ 121 $ 1,973 Less: allowance for credit losses (6) (99) Short-term payment plans, net $ 115 $ 1,874 Long-Term Financing Arrangements Additionally, the Company provides financing for purchases of its information and patient care systems to certain healthcare providers under long-term financing arrangements expiring in various years through 2026. Under long-term financing arrangements, the transaction price is adjusted by a discount rate that reflects market conditions and that would be used for a separate financing transaction between the Company and licensee at contract inception, and takes into account the credit characteristics of the licensee and market interest rates as of the date of the agreement. As such, the amount of fixed fee revenue recognized at the beginning of the license term will be reduced by the calculated financing component. As payments are received from the licensee, the Company recognizes a portion of the financing component as interest income, reported as other income in the consolidated statements of operations. These receivables typically have terms from two The components of these receivables were as follows on December 31, 2021 and 2020: (In thousands) 2021 2020 Long-term financing arrangements, gross $ 15,659 $ 24,082 Less: allowance for credit losses (716) (1,390) Less: unearned income (1,339) (2,268) Long-term financing arrangements, net $ 13,604 $ 20,424 Future minimum payments to be received subsequent to December 31, 2021 are as follows: (In thousands) 2022 $ 7,060 2023 4,393 2024 2,726 2025 1,309 2026 153 Thereafter 18 Total minimum payments to be received 15,659 Less: allowance for credit losses (716) Less: unearned income (1,339) Receivables, net $ 13,604 Credit Quality of Financing Receivables and Allowance for Credit Losses The following table is a roll-forward of the allowance for financing credit losses for the years ended December 31, 2021 and 2020: (In thousands) Beginning Balance Provision Charge-offs Recoveries Ending Balance December 31, 2021 $ 1,489 $ 481 $ (1,248) $ — $ 722 December 31, 2020 $ 2,971 $ 1,632 $ (3,114) $ — $ 1,489 The Company’s financing receivables are comprised of a single portfolio segment, as the balances are all derived from short-term payment plan arrangements and long-term financing arrangements within our target market of community hospitals. The Company evaluates the credit quality of its financing receivables based on a combination of factors, including, but not limited to, customer collection experience, economic conditions, the customer’s financial condition, and known risk characteristics impacting the respective customer base of community hospitals, the most notable of which relate to enacted and potential changes in Medicare and Medicaid reimbursement rates as community hospitals typically generate a significant portion of their revenues and related cash flows from beneficiaries of these programs. In addition to specific account identification, the Company utilizes historical collection experience to establish the allowance for credit losses. Financing receivables are written off only after the Company has exhausted all collection efforts. Write-off amounts during 2020 were uncharacteristically high as we wrote off large balances for a handful of customers for which specific reserves had been established as of December 31, 2019. Write-off amounts normalized during 2021. Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms. To facilitate customer collection and credit monitoring efforts, financing receivable amounts are invoiced and reclassified to trade accounts receivable when they become due, with all invoiced amounts placed on nonaccrual status. As a result, all past due amounts related to the Company’s financing receivables are included in trade accounts receivable in the accompanying consolidated balance sheets. The following is an analysis of the age of financing receivables amounts (excluding short-term payment plans) that have been reclassified to trade accounts receivable and were past due as of December 31, 2021 and 2020: (In thousands) 1 to 90 Days Past Due 91 to 180 Days Past Due 181 + Days Past Due Total Past Due December 31, 2021 $ 713 $ 78 $ 73 $ 864 December 31, 2020 $ 1,270 $ 227 $ 672 $ 2,169 From time to time, the Company may agree to alternative payment terms outside of the terms of the original financing receivable agreement due to customer difficulties in achieving the original terms. In general, such alternative payment arrangements do not result in a re-aging of the related receivables. Rather, payments pursuant to any alternative payment arrangements are applied to the already outstanding invoices beginning with the oldest outstanding invoices as the payments are received. Because amounts are reclassified to trade accounts receivable when they become due, there are no past due amounts included within the financing receivables or the financing receivables, current portion, net amounts in the accompanying consolidated balance sheets. The Company utilizes an aging of trade accounts receivable as the primary credit quality indicator for its financing receivables, which is facilitated by the reclassification of customer payment amounts to trade accounts receivable when they become due. The table below categorizes customer financing receivable balances (excluding short term payment plans), none of which are considered past due, based on the age of the oldest payment outstanding that has been reclassified to trade accounts receivable: (In thousands) December 31, 2021 December 31, 2020 Stratification of uninvoiced client financing receivables based on aging of related trade accounts receivable: Uninvoiced client financing receivables related to trade accounts receivable that are 1 to 90 Days Past Due $ 9,100 $ 11,719 Uninvoiced client financing receivables related to trade accounts receivable that are 91 to 180 Days Past Due 329 1,092 Uninvoiced client financing receivables related to trade accounts receivable that are 181+Days Past Due 386 2,668 Total uninvoiced client financing receivables balances of clients with a trade accounts receivable $ 9,815 $ 15,479 Total uninvoiced client financing receivables of clients with no related trade accounts receivable 4,505 6,335 Total financing receivables with contractual maturities of one year or less 121 1,973 Less: allowance for credit losses (722) (1,489) Total financing receivables $ 13,719 $ 22,298

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	INTANGIBLE ASSETS AND GOODWILL Our purchased definite-lived intangible assets as of December 31, 2021 and 2020 are summarized as follows: December 31, 2021 (In thousands) Customer Relationships Trademark Developed Technology Total Gross carrying amount, beginning of period $ 84,370 $ 11,120 $ 29,700 $ 125,190 Intangible assets acquired 28,200 1,200 7,900 37,300 Accumulated amortization (41,738) (5,177) (20,372) (67,287) Net intangible assets as of December 31, 2021 $ 70,832 $ 7,143 $ 17,228 $ 95,203 Weighted average remaining years of useful life 9 13 8 10 December 31, 2020 (In thousands) Customer Relationships Trademark Developed Technology Total Gross carrying amount, beginning of period $ 84,370 $ 11,120 $ 29,700 $ 125,190 Accumulated amortization (33,612) (4,297) (15,592) (53,501) Net intangible assets as of December 31, 2020 $ 50,758 $ 6,823 $ 14,108 $ 71,689 The following table represents the remaining amortization of definite-lived intangible assets as of December 31, 2021: (In thousands) For the year ended December 31, 2022 $ 14,688 2023 12,800 2024 11,266 2025 10,950 2026 10,328 Due thereafter 35,171 Total $ 95,203 The following table sets forth the change in the carrying amount of goodwill by segment for the years ended December 31, 2021, 2020, and 2019: (In thousands) Acute Care EHR Post-acute Care EHR TruBridge Total Balance as of December 31, 2018 $ 97,095 $ 29,570 $ 13,784 $ 140,449 Goodwill acquired — — 9,767 9,767 Balance as of December 31, 2019 97,095 29,570 23,551 150,216 Balance as of December 31, 2020 97,095 29,570 23,551 150,216 Goodwill acquired $ — — 27,497 27,497 Balance as of December 31, 2021 $ 97,095 $ 29,570 $ 51,048 $ 177,713 We determined there was no impairment to goodwill as of December 31, 2021, 2020, or 2019.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Long-Term Debt	LONG-TERM DEBT Long-term debt was comprised of the following at December 31, 2021 and 2020: (In thousands) December 31, 2021 December 31, 2020 Term loan facility $ 69,375 $ 73,125 Revolving credit facility 31,000 5,000 Debt obligations 100,375 78,125 Less: debt issuance costs (1,015) (1,308) Debt obligation, net 99,360 76,817 Less: current portion (4,394) (3,457) Long-term debt $ 94,966 $ 73,360 As of December 31, 2021, the carrying value of debt approximates the fair value due to the variable interest rate which reflects market rates. Credit Agreement In conjunction with our acquisition of HHI in January 2016, we entered into a syndicated credit agreement with Regions Bank ("Regions") serving as administrative agent, which provided for a $125 million term loan facility and a $50 million revolving credit facility. On June 16, 2020, we entered into an Amended and Restated Credit Agreement that increased the aggregate principal amount of our credit facilities to $185 million, which includes a $75 million term loan facility and a $110 million revolving credit facility. Each of our credit facilities continues to bear interest at a rate per annum equal to an applicable margin plus, at our option, either (1) the Adjusted LIBOR rate for the relevant interest period, subject to a floor of 0.50%, (2) an alternate base rate determined by reference to the greater of (a) the prime lending rate of Regions, (b) the federal funds rate for the relevant interest period plus one half of one percent per annum and (c) the one month LIBOR rate, subject to the aforementioned floor, plus one percent per annum, or (3) a combination of (1) and (2). The applicable margin range for LIBOR loans and the letter of credit fee ranges from 1.8% to 3.0%. The applicable margin range for base rate loans ranges from 0.8% to 2.0%, in each case based on the Company's consolidated net leverage ratio. Principal payments with respect to the term loan facility are due on the last day of each fiscal quarter beginning September 30, 2020, with quarterly principal payments of approximately $0.9 million through June 30, 2022, approximately $1.4 million through June 30, 2024 and approximately $1.9 million through March 31, 2025, with maturity on June 16, 2025 or such earlier date as the obligations under the Amended and Restated Credit Agreement become due and payable pursuant to the terms of such agreement. Any principal outstanding under the revolving credit facility is due and payable on the maturity date. Anticipated annual future maturities of the term loan facility and revolving credit facility are as follows as of December 31, 2021: (In thousands) 2022 $ 4,687 2023 5,625 2024 6,563 2025 83,500 Thereafter — $ 100,375 Our credit facilities are secured pursuant to an Amended and Restated Pledge and Security Agreement, dated June 16, 2020, among the parties identified as obligors therein and Regions, as collateral agent, on a first priority basis by a security interest in substantially all of the tangible and intangible assets (subject to certain exceptions) of the Company and certain subsidiaries of the Company, as guarantors (collectively, the “Subsidiary Guarantors”), including certain registered intellectual property and the capital stock of certain of the Company’s direct and indirect subsidiaries. Our obligations under the Amended and Restated Credit Agreement are also guaranteed by the Subsidiary Guarantors. The Amended and Restated Credit Agreement provides incremental facility capacity of $50 million, subject to certain conditions. The Amended and Restated Credit Agreement includes a number of restrictive covenants that, among other things and in each case subject to certain exceptions and baskets, impose operating and financial restrictions on the Company and the Subsidiary Guarantors, including the ability to incur additional debt; incur liens and encumbrances; make certain restricted payments, including paying dividends on the Company's equity securities or payments to redeem, repurchase or retire the Company's equity securities (which are subject to our compliance, on a pro forma basis to give effect to the restricted payment, with the fixed charge coverage ratio and consolidated net leverage ratio described below); enter into certain restrictive agreements; make investments, loans and acquisitions; merge or consolidate with any other person; dispose of assets; enter into sale and leaseback transactions; engage in transactions with affiliates; and materially alter the business we conduct. The Amended and Restated Credit Agreement requires the Company to maintain a minimum fixed charge coverage ratio of 1.25:1.00 throughout the duration of such agreement. Under the Amended and Restated Credit Agreement, the Company is required to comply with a maximum consolidated net leverage ratio of 3.50:1.00. The Amended and Restated Credit Agreement also contains customary representations and warranties, affirmative covenants and events of default. We believe that we were in compliance with the covenants contained in the credit agreement as of December 31, 2021. The Amended and Restated Credit Agreement requires the Company to mandatorily prepay our credit facilities with 50% of excess cash flow (minus certain specified other payments). This mandatory prepayment requirement is applicable only if the Company's net leverage ratio exceeds 2.50:1.00. The Company is permitted to voluntarily prepay our credit facilities at any time without penalty, subject to customary “breakage” costs with respect to prepayments of LIBOR rate loans made on a day other than the last day of any applicable interest period. The excess cash flow mandatory prepayment requirement under the credit agreement did not result in a prepayment in 2021 or 2020.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Benefit Plans	BENEFIT PLANS In January 1994, the Company adopted the CPSI 401(k) Retirement Plan that covers all eligible employees of the Company. The plan allows eligible employees to contribute up to 60% of their pre-tax earnings up to the statutory limit prescribed by the Internal Revenue Service. The Company matches a discretionary amount determined by the Board of Directors. The Company contributed approximately $3.2 million, $3.2 million, and $2.9 million to the plan for the years ended December 31, 2021, 2020 and 2019, respectively. The Company provides certain health and medical benefits to eligible employees, their spouses and dependents pursuant to a benefit plan funded by the Company. Each participating employee contributes to the Company’s costs associated with such benefit plan. The Company’s obligation to fund this benefit plan and pay for these benefits is limited through the Company’s purchase of an insurance policy from a third-party insurer. The amount established as a reserve is intended to recognize the Company’s estimated obligations with respect to its payment of claims and claims incurred but not yet reported under the benefit plan. Management believes that the recorded liability for medical self-insurance at December 31, 2021 and 2020 is adequate to cover the losses and claims incurred, but these reserves are based on estimates and the amount ultimately paid may be more or less than such estimates.

Operating Leases

Operating Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Operating Leases	OPERATING LEASES The Company leases office space in various locations in Alabama, Pennsylvania, Minnesota, Maryland, and Mississippi. These leases have terms expiring from 2022 through 2030 but do contain optional extension terms. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We recognize lease expense on a straight-line basis over the lease term. On July 28, 2021, the Company terminated its lease agreement for approximately 45,000 square feet of office space in Fairhope, Alabama. Pursuant to a Termination of Lease Agreement dated July 28, 2021, the Company paid $0.9 million to the landlord as consideration for the early termination. In connection with the lease termination, the Company derecognized the assets and liabilities associated with the operating lease and recorded a $0.3 million loss on the disposal of leasehold improvements. Supplemental balance sheet information related to operating leases is as follows: (In thousands) December 31, 2021 Operating lease assets: Operating lease assets $ 7,097 Operating lease liabilities: Other accrued liabilities 1,592 Operating lease liabilities, net of current portion 5,505 Total operating lease liabilities $ 7,097 Weighted average remaining lease term in years 6 Weighted average discount rate 4.6% Because our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. We used the incremental borrowing rate on January 1, 2019, for operating leases that commenced prior to that date. The future minimum lease payments payable under these operating leases subsequent to December 31, 2021 are as follows: (In thousands) 2022 $ 1,592 2023 1,520 2024 1,411 2025 1,202 2026 1,225 Thereafter 1,115 Total lease payments 8,065 Less imputed interest (968) Total $ 7,097 Total rent expense for the years ended December 31, 2021, 2020, and 2019 was $1.8 million, $1.7 million, and $2.2 million, respectively. Total cash paid for amounts included in the measurement of lease liabilities within operating cash flows from operating leases for the year ended December 31, 2021 was $1.8 million.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIESFrom time to time, the Company is involved in routine litigation that arises in the ordinary course of business. Management does not believe it is reasonably possible that such matters will have a material adverse effect on the Company’s financial statements.

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value	FAIR VALUE ASC 820, Fair Value Measurements and Disclosures, establishes a framework for measuring fair value and expands financial statement disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Codification topic does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. The Codification topic requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. As of December 31, 2021, we measured the fair value of contingent consideration that represents the potential earnout incentive for TruCode’s former equity holders. We estimated the fair value of the contingent consideration based on the probability of TruCode meeting EBITDA targets (subject to certain pro-forma adjustments). We did not have any other instruments that required fair value measurement as of December 31, 2021. The following table summarizes the carrying amount and fair value of the contingent consideration at December 31, 2021: Fair Value at December 31, 2021 Using (In thousands) Carrying Amount at 12/31/21 Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Description Contingent Consideration $ 2,500 $ — $ — $ 2,500 Total $ 2,500 $ — $ — $ 2,500

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment Reporting	SEGMENT REPORTING Our chief operating decision makers ("CODM") utilize three operating segments, "Acute Care EHR", "Post-acute Care EHR" and "TruBridge", based on our three distinct business units with unique market dynamics and opportunities. Revenues and costs of sales are primarily derived from the provision of services and sales of our proprietary software, and our CODM assess the performance of these three segments at the gross profit level. Operating expenses and items such as interest, income tax, capital expenditures and total assets are managed at a consolidated level and thus are not included in our operating segment disclosures. Our CODM group is comprised of the Chief Executive Officer, Chief Growth Officer, Chief Operating Officer, and Chief Financial Officer. Accounting policies for each of the reportable segments are the same as those used on a consolidated basis. The following table presents a summary of the revenues, cost of sales, and gross profit of our three operating segments for the years ended December 31, 2021, 2020, and 2019: Year Ended December 31, (In thousands) 2021 2020 2019 Revenues: Acute Care EHR Recurring revenue $ 108,440 $ 105,597 $ 109,046 Non-recurring revenue 16,939 29,173 35,028 Total Acute Care EHR revenue 125,379 134,770 144,074 Post-acute Care EHR Recurring revenue 16,472 16,272 17,466 Non-recurring revenue 1,258 1,912 3,812 Total Post-acute Care EHR revenue 17,730 18,184 21,278 TruBridge 137,520 111,534 109,282 Total revenues 280,629 264,488 274,634 Cost of sales: Acute Care EHR 65,776 64,540 68,569 Post-acute Care EHR 4,888 4,821 5,303 TruBridge 69,083 58,881 56,617 Total cost of sales 139,747 128,242 130,489 Gross profit: Acute Care EHR 59,603 70,230 75,505 Post-acute Care EHR 12,842 13,363 15,975 TruBridge 68,437 52,653 52,665 Total gross profit 140,882 136,246 144,145 Corporate operating expenses (116,175) (115,192) (119,562) Other income 1,529 1,494 807 Gain on contingent consideration — — 5,000 Loss on extinguishment of debt — (202) — Interest expense (3,160) (3,562) (6,694) Income before taxes $ 23,076 $ 18,784 $ 23,696

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS On March 1, 2022, the Company acquired all of the assets and liabilities of Healthcare Resource Group, Inc., a Washington corporation ("HRG"), pursuant to a Stock Purchase Agreement dated March 1, 2022. Based in Spokane, Washington, HRG is a leading provider of customized RCM solutions and consulting services that enable hospitals and clinics to improve efficiency, profitability, and patient satisfaction. The Stock Purchase Agreement provides for a total purchase price of $44.0 million, subject to various upward or downward adjustments, including for working capital, cash, indebtedness, and transaction expenses of HRG. Due to the proximity of the acquisition date to the Company's filing of its Annual Report on Form 10-K for the year ended December 31, 2021, the initial accounting for the HRG business combination is incomplete, and therefore the Company is unable to disclose certain information required by ASC 805, Business Combinations, including the provisional amounts recognized as of the acquisition date for each major class of assets acquired, liabilities assumed and goodwill. A preliminary valuation assessment is expected to be provided on our quarterly report on Form 10-Q for the three month ended March 31, 2022.

COVID-19 Pandemic

COVID-19 Pandemic	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
COVID-19 Pandemic	COVID-19 PANDEMIC In December 2019, a novel coronavirus disease ("COVID-19") was reported, and in January 2020, the World Health Organization ("WHO") declared it a Public Health Emergency of International Concern. In February 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and in March 2020, the WHO characterized COVID-19 as a pandemic and the President of the United States declared the COVID-19 outbreak a national emergency. The COVID-19 pandemic has caused, and is continuing to cause, severe economic, market, and other disruptions to the U.S. and global economies. The Company began experiencing adverse business conditions beginning in the latter half of March 2020, which have persisted through the date of this report, including the results of operations for the year ended December 31, 2021. Most notably: • Travel restrictions and social distancing protocols have created an additional challenge to our on-site implementation and sales teams. Although we have shown success with remote implementation models and our sales representatives are engaging in remote contact with existing customers and prospects, these restrictions and protocols are expected to continue to have an incrementally negative impact on implementation revenues and new sales generation. • Although patient volumes at our client hospitals have largely recovered from the severe declines in such volumes experienced during much of 2020, there can be no guarantee as to the permanence of this recovery. As the overwhelming majority of TruBridge revenues are directly or indirectly correlated with client patient volumes, any further reduction in these patient volumes may negatively impact our related revenues. • Although we have experienced no notable disruption to our operating cash flows through the date of this report, the aforementioned limitations on travel and decreased client patient volumes increase the risk of decreased cash collections from our customers as long as these conditions persist. Such decreases in cash collections could be further negatively impacted by the amount and extent to which the pandemic impacts the financial condition and liquidity of our customers.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2021
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	VALUATION AND QUALIFYING ACCOUNTS (In thousands) Description Balance at beginning of period Additions charged to cost and expenses (1) Deductions (2) Balance at end of period Allowance for credit losses deducted from accounts receivable in the balance sheet 2019 $ 2,124 $ 1,378 $ (1,424) $ 2,078 2020 $ 2,078 $ 2,825 $ (3,202) $ 1,701 2021 $ 1,701 $ 2,111 $ (1,986) $ 1,826 (1) Adjustments to allowance for change in estimates. (2) Uncollectible accounts written off, net of recoveries. Description Balance at beginning of period Additions charged to cost and expenses (1) Deductions (2) Balance at end of period Allowance for credit losses deducted from financing receivables in the balance sheet 2019 $ 2,567 $ 970 $ (566) $ 2,971 2020 $ 2,971 $ 1,632 $ (3,114) $ 1,489 2021 $ 1,489 $ 481 $ (1,248) $ 722 (1) Adjustments to allowance for change in estimates. (2) Uncollectible accounts written off, net of recoveries.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements of CPSI include the accounts of TruBridge, LLC ("TruBridge"), Evident, LLC ("Evident"), iNetXperts, Corp. d/b/a Get Real Health ("Get Real Health"), Healthland Holding Inc. ("HHI"), and TruCode, LLC ("TruCode"), all of which are wholly-owned subsidiaries of CPSI. The accounts of HHI include those of its wholly-owned subsidiaries, Healthland Inc. ("Healthland"), Rycan Technologies, Inc. ("Rycan"), and American HealthTech, Inc. ("AHT"). All significant intercompany balances and transactions have been eliminated.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents can include time deposits and certificates of deposit with original maturities of three months or less that are highly liquid and readily convertible to a known amount of cash. These assets are stated at cost, which approximates market value, due to their short duration or liquid nature.
Change in Useful Lives of Intangible Assets	Change in Useful Lives of Intangible Assets In accordance with its policy, the Company reviews the estimated useful lives of its intangible assets on an ongoing basis. This review indicated that the actual lives of certain developed technology were shorter than the estimated useful lives used for amortization purposes in the Company's financial statements. As a result, effective January 1, 2021, the Company changed its estimates of the useful lives of certain developed technology to better reflect the estimated periods during which these assets will remain in service. The remaining useful life of certain developed technology that was 3.25 years at January 1, 2021 was reduced to 2 years, while the remaining useful life of certain developed technology that was 4.25 years was reduced to 3 years. The effect of this change was to increase 2021 amortization expense by approximately $1.0 million and decrease 2021 net income and basic and diluted earnings per share by $0.8 million and $0.06, respectively.
Presentation	PresentationEffective January 1, 2021, costs associated with our internal legal, compliance, and contract administration activities, which were formerly included within the caption “Sales and marketing” on our consolidated statements of operations, have been recorded as a component of “General and administrative” expenses. Amounts presented for the years ended December 31, 2020 and 2019, have been reclassified to conform to the current presentation.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company establishes a general allowance for credit losses based on collections history. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific allowance for credit losses may be recorded to reduce the related receivable to the amount expected to be recovered.
Financing Receivables	Financing Receivables Financing receivables are comprised of short-term payment plans and sales-type leases. Short-term payment plans are stated at the amount the Company expects to collect and do not bear interest. Sales-type leases are initially recorded at the present value of the related minimum lease payments. An allowance for credit losses has been established for our financing receivables based on the historical level of customer defaults under such arrangements. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific reserve may be recorded to reduce the related receivable to the amount expected to be recovered. Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms, with amounts reclassified to accounts receivable when they become due. As a result, we evaluate the credit quality of our financing receivables on an ongoing basis utilizing an aging of receivables and write-offs, customer collection experience, the customer’s financial condition and known risk characteristics impacting the respective customer base, as well as existing economic conditions, to determine if any further allowance is necessary. Amounts are specifically charged off once all available means of collection have been exhausted.
Inventories	InventoriesInventories are stated at lower of cost or net realizable value using the average cost method. The Company’s inventories are comprised of computer equipment, forms and supplies.
Property and Equipment	Property and Equipment Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements to property and equipment that materially increase productive capacity or extend the life of an asset are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other disposition of such assets, the related costs and accumulated depreciation are removed from the respective accounts and any resulting gain or loss is included in the results of operations. Depreciation expense is computed using the straight-line method over the asset’s useful life, which is generally 5 years for computer equipment, furniture, and fixtures and 30 years for buildings. Leasehold improvements are depreciated over the shorter of the asset’s useful life or the remaining lease term. The Company reviews for the possible impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation expense is reported in the consolidated statements of operations as a component of costs of sales and operating expenses.
Business Combinations	Business Combinations We apply business combination accounting when we acquire a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded in general and administrative expenses; restructuring costs associated with a business combination are expenses; contingent consideration is measured at fair value at the acquisition date, with changes in fair value after the acquisition date affecting earnings; changes in deferred tax asset valuation allowances and income tax uncertainties after the measurement period affect income tax expense; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net
Goodwill	Goodwill Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the identifiable net tangible and intangible assets acquired. Goodwill is not amortized but is evaluated for impairment annually or more frequently if indicators of impairment are present or changes in circumstances suggest that impairment may exist. We test annually for impairment as of October 1. As part of our annual goodwill impairment test, we first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we conduct a quantitative goodwill impairment assessment, which compares the fair value of the reporting unit with its carrying amount, including goodwill. If the carrying amount of the reporting unit exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the total amount of goodwill allocated to that reporting unit. If the fair value of the reporting unit exceeds its carrying amount, the goodwill of the reporting unit is not considered to be impaired. We determined there was no impairment to goodwill for the years ended December 31, 2021, 2020 and 2019.
Purchased Intangible Assets	Purchased Intangible Assets Purchased intangible assets are acquired in connection with a business acquisition, and are amortized over their estimated useful lives based on the pattern of economic benefit expected from each asset. We concluded for certain purchased intangible assets that the pattern of economic benefit approximated the straight-line method, and therefore, the use of the straight-line method was appropriate, as the majority of the cash flows will be recognized ratably over the estimated useful lives and there is no degradation of the cash flows over time. We assess the recoverability of intangible assets whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The carrying amount is not recoverable if it exceeds the undiscounted sum of cash flows expected to result from the use and eventual disposition of the asset. If the asset is not recoverable, the impairment loss is measured by the excess of the asset's carrying amount over its fair value. We determined there was no impairment to purchased intangible assets as of December 31, 2021, 2020 or 2019.
Revenue Recognition	Revenue Recognition Revenue is recognized upon transfer of control of promised products or services to clients in an amount that reflects the consideration we expect to receive in exchange for those products and services. We enter into contracts that can include various combinations of products and services, which are generally distinct and accounted for as separate performance obligations. The Company employs the 5-step revenue recognition model under ASC 606, Revenue from Contracts with Customers, to: (1) identify the contract with the client, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue is recognized net of shipping charges and any taxes collected from clients, which are subsequently remitted to governmental authorities. • System Sales and Support The Company enters into contractual obligations to sell perpetual software licenses, installation, conversion, and related training services, software application support, hardware, and hardware maintenance services to acute care community hospitals and post-acute providers. • Non-recurring Revenues • Perpetual software licenses and installation, conversion, and related training services are not considered separate and distinct performance obligations due to the proprietary nature of our software and are, therefore, accounted for as a single performance obligation on a module-by-module basis. Revenue is recognized as each module's implementation is completed based on the module's stand-alone selling price ("SSP"), net of discounts. We determine each module's SSP using the residual method. Fees for licenses and installation, conversion, and related training services are typically due in three installments: (1) at placement of order, (2) upon installation of software and commencement of training, and (3) upon satisfactory completion of monthly accounting cycle or end-of-month operation by application and as applicable for each application. Often, short-term and/or long-term financing arrangements are provided for software implementations; refer to Note 11 - Financing Receivables for further information. Electronic health records ("EHR") implementations include a system warranty that terminates thirty days from the software go-live date, the date which the client begins using the system in a live environment. • Hardware revenue is recognized separately from software licenses at the point in time it is delivered to the client. The SSP of hardware is cost plus a reasonable margin and revenue is recognized on a gross basis. Payment is generally due upon delivery of the hardware to the client. Standard manufacturer warranties apply to hardware. • Recurring Revenues • Software application support and hardware maintenance services sold with software licenses and hardware are separate and distinct performance obligations. Revenue for support and maintenance services is recognized based on SSP, which is the renewal price, ratably over the life of the contract, which is generally three • Subscriptions to third-party content revenue is recognized as a separate performance obligation ratably over the subscription term based on SSP, which is cost plus a reasonable margin, and revenue is recognized on a gross basis. Payment is due monthly for subscriptions to third party content. • Software as a Service ("SaaS") arrangements for EHR software and related conversion and training services are considered a single performance obligation. Revenue is recognized on a monthly basis as the SaaS service is provided to the client over the contract term. Payment is due monthly for SaaS services provided. Refer to Note 18 - Segment Reporting for further information, including revenue by client base (acute care or post-acute care) bifurcated by recurring and non-recurring revenue. • TruBridge TruBridge provides an array of business processing services ("BPS") consisting of accounts receivable management, private pay services, insurance services, medical coding, electronic billing, statement processing, payroll processing, and contract management. Fees are recognized over the period of the client contractual relationship as the services are performed based on the SSP, net of discounts. SSP for TruBridge BPS services is determined based on observable stand-alone selling prices. Fees for many of these services are invoiced, and revenue recognized accordingly, based on the volume of transactions or a percentage of client accounts receivable collections. Payment is due monthly for BPS with certain amounts varying based on utilization and/or volumes. TruBridge also provides professional IT services. Revenue from professional IT services is recognized as the services are performed based on SSP, which is determined by observable stand-alone selling prices. Payment is due monthly as services are performed. Lastly, TruBridge also provides certain software solutions and related support under SaaS arrangements and time-based software licenses. Revenue from SaaS arrangements is recognized in a manner consistent with SaaS arrangements for EHR software, as discussed above. Revenue from time-based software licenses is recognized upon delivery to the client (“point in time”) and revenue from non-license components (i.e., support) is recognized ratably over the respective contract term (“over time”). SSP for time-based licenses is determined using the residual approach, while the non-license component is based on cost plus reasonable margin. • Deferred Revenue Deferred revenue represents amounts invoiced to clients for which the services under contract have not been completed and revenue has not been recognized, including annual renewals of certain software subscriptions and customer deposits for implementations to be performed at a later date. Revenue is recognized ratably over the life of the software subscriptions as services are provided and at the point-in-time when implementations have been completed. The following table details deferred revenue for the years ended December 31, 2021 and 2020, included in the consolidated balance sheets: For years ended December 31, (In thousands) 2021 2020 Beginning balance $ 8,130 $ 8,628 Deferred revenue recorded 23,393 18,507 Deferred revenue acquired 1,300 — Less deferred revenue recognized as revenue (21,294) (19,005) Ending balance $ 11,529 $ 8,130 The deferred revenue recorded for years ended December 31, 2021 and 2020 is comprised primarily of the annual renewals of certain software subscriptions billed during the first quarter of each year and deposits collected for future EHR installations. The deferred revenue acquired resulted from the May 2021 acquisition of TruCode. The deferred revenue recognized as revenue during the years ended December 31, 2021 and 2020 is comprised primarily of the periodic recognition of annual renewals that were deferred until earned and deposits for future EHR installations that were deferred until earned. • Costs to Obtain and Fulfill a Contract with a Customer Costs to obtain a contract include the commission costs related to SaaS arrangements, which are capitalized and amortized ratably over the expected life of the customer. As a practical expedient, we generally recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset would have been one year or less, with the exception of commissions generated from TruBridge sales. TruBridge commissions, which are paid up to twelve months in advance, are capitalized and amortized over the prepayment period. Costs to obtain a contract are expensed within sales and marketing expenses in the accompanying consolidated statements of operations. Contract fulfillment costs related to the implementation of SaaS arrangements are capitalized and amortized ratably over the expected life of the customer. Costs to fulfill contracts consist of the payroll costs for the implementation of SaaS arrangements, including time for training, conversion, and installation that is necessary for the software to be utilized. Contract fulfillment costs are expensed within the caption "System sales and support - Cost of sales" in the accompanying consolidated statements of operations. Costs to obtain and fulfill contracts related to SaaS arrangements are included within the "Prepaid expenses and other" and "Other assets, net of current portion" line items on our consolidated balance sheets. The following table details costs to obtain and fulfill contracts with customers for the years ended December 31, 2021 and 2020, included in the consolidated balance sheets: For years ended December 31, (In thousands) 2021 2020 Beginning balance $ 5,992 $ 4,439 Costs to obtain and fulfill contracts capitalized 7,256 6,974 Less costs to obtain and fulfill contracts recognized as expense (5,936) (5,421) Ending balance $ 7,312 $ 5,992 • Significant Judgments Our contracts with clients often include promises to transfer multiple products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Judgment is required to determine SSP for each distinct performance obligation. We use observable SSP for items that are sold on a stand-alone basis to similarly situated clients at unit prices within a sufficiently narrow range. For performance obligations that are sold to different clients for a broad range of amounts, or for performance obligations that are never sold on a stand-alone basis, the residual method in determining SSP is applied and requires significant judgment. Allocating the transaction price, including estimating SSP of promised goods and services for contracts with discounts or variable consideration, may require significant judgment. Due to the short time frame of the implementation cycle, discount allocation is immaterial as revenue is recognized net of discounts within the same reporting period. In scenarios where the Company enters into a contract that includes both a software license and BPS or other services that are charged based on volume of services rendered, the Company allocates variable amounts entirely to a distinct good or service. The terms of the variable payment relate specifically to the entity’s efforts to satisfy that performance obligation. Significant judgment is required in determining the expected life of a customer, which is the amortization period for costs to obtain and fulfill a contract that have been capitalized. The Company determined that the expected life of the customer is not materially different from the initial contract term based on the characteristics of the SaaS offering. • Remaining Performance Obligations Disclosures regarding remaining performance obligations are not considered material as the overwhelming majority of the Company's remaining performance obligations either (a) are related to contracts with an expected duration of one year or less, or (b) exhibit revenue recognition in the amount to which the Company has the right to invoice.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation according to the provisions of ASC 718, Compensation – Stock Compensation , which establishes accounting for stock-based awards exchanged for employee services. Accordingly, stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period.
Software Development Costs	Software Development Costs Our software solutions are offered to our clients through both traditional perpetual licenses as well as SaaS delivery models. Development costs associated with the certain solutions offered exclusively through a SaaS model are accounted for in accordance with ASC 350-40, Internal Use Software . All other client solution development costs are accounted for in accordance with ASC 985-20, Costs of Software to be Sold, Leased, or Marketed . Under ASC 985-20, software development costs incurred in creating computer software solutions are expensed until technological feasibility has been established upon completion of a detailed program design or, in the absence of a detailed program design, upon completion of a product design and working model of the software product. Thereafter, all software development costs incurred through the software’s general release date are capitalized and subsequently recorded at the lower of amortized cost or net realizable value. Capitalized costs are amortized based on the current and expected future revenue for each software solution with minimum annual amortization equal to the straight-line amortization over the estimated economic life of the solution, which is estimated to be five years. Under ASC 350-40, software development costs related to preliminary project activities and post-implementation and maintenance activities are expensed as incurred. We capitalize direct costs related to application development activities that are probable to result in additional functionality. Capitalized costs are amortized on a straight-line basis over five years. We test for impairment whenever events or changes in circumstances that could impact recoverability occur. See Note 5 - Software Development for further information relating to our software development costs.
Income Taxes	Income Taxes We account for income taxes in accordance with ASC 740, Accounting for Income Taxes . Under this topic, deferred income taxes are determined utilizing the asset and liability approach. This method gives consideration to the future tax consequences associated with differences between financial accounting and tax bases of assets and liabilities. The effect on the deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We recognize interest and penalties accrued related to unrecognized tax benefits in the consolidated statements of operations as a component of the provision for income taxes. We also make a provision for uncertain income tax positions in accordance with the ASC 740, Accounting for Income Taxes . These provisions require that a tax position taken in a tax return be recognized in the financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon settlement. The topic also requires that changes in judgment that result in subsequent recognition, derecognition, or change in a measurement date of a tax position taken in a prior annual period (including any related interest and penalties) be recognized as a discrete item in the interim period in which the change occurs.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Segment Reporting	Segment Reporting Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, which we refer to as the CODM, or decision-making group in assessing performance and making decisions regarding resource allocation. The Company has prepared operating segment information based on the manner in which management disaggregates the Company's operations for making internal operating decisions. For more information, see Note 18 - Segment Reporting.
New Accounting Standards Adopted in 2021 and New Accounting Standards Yet to be Adopted	New Accounting Standards Adopted in 2021 There were no new accounting standards required to be adopted in 2021 that would have a material impact on our consolidated financial statements. New Accounting Standards Yet to be Adopted We do not believe that any recently issued but not yet effective accounting standards, if adopted, would have a material impact on our consolidated financial statements.
Net Income Per Share	The Company presents basic and diluted earnings per share ("EPS") data for its common stock. Basic EPS is calculated by dividing the net income attributable to stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all dilutive potential common shares, including awards under stock-based compensation arrangements. The Company's unvested restricted stock awards (see Note 9) are considered participating securities under ASC 260, Earnings Per Share , because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited. When a company has a security that qualifies as a "participating security," the Codification requires the use of the two-class method when computing basic EPS. The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net income to allocate to common stockholders, income is allocated to both common stock and participating securities based on their respective weighted average shares outstanding for the period, with net income attributable to common stockholders ultimately equaling net income less net income attributable to participating securities. Diluted EPS for the Company's common stock is computed using the more dilutive of the two-class method or the treasury stock method.
Fair Value	ASC 820, Fair Value Measurements and Disclosures, establishes a framework for measuring fair value and expands financial statement disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Codification topic does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. The Codification topic requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principle	The following table provides the amount reclassified for the year ended December 31, 2020: (in thousands) As previously reported Re-classifications As reclassified Operating expenses Sales and marketing $ 24,185 $ (1,350) $ 22,835 General and administrative $ 46,129 $ 1,350 $ 47,479 The following table provides the amount reclassified for the year ended December 31, 2019: (in thousands) As previously reported Re-classifications As reclassified Operating expenses Sales and marketing $ 27,774 $ (1,279) $ 26,495 General and administrative $ 43,921 $ 1,279 $ 45,200
Schedule of Contract with Customer, Asset and Liability	The following table details deferred revenue for the years ended December 31, 2021 and 2020, included in the consolidated balance sheets: For years ended December 31, (In thousands) 2021 2020 Beginning balance $ 8,130 $ 8,628 Deferred revenue recorded 23,393 18,507 Deferred revenue acquired 1,300 — Less deferred revenue recognized as revenue (21,294) (19,005) Ending balance $ 11,529 $ 8,130
Schedule of Changes in Capitalized Contract Cost	Costs to obtain and fulfill contracts related to SaaS arrangements are included within the "Prepaid expenses and other" and "Other assets, net of current portion" line items on our consolidated balance sheets. The following table details costs to obtain and fulfill contracts with customers for the years ended December 31, 2021 and 2020, included in the consolidated balance sheets: For years ended December 31, (In thousands) 2021 2020 Beginning balance $ 5,992 $ 4,439 Costs to obtain and fulfill contracts capitalized 7,256 6,974 Less costs to obtain and fulfill contracts recognized as expense (5,936) (5,421) Ending balance $ 7,312 $ 5,992

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The allocation of the purchase price paid for TruCode was as follows: (In thousands) Purchase Price Allocation Acquired cash $ 4,249 Accounts receivable 924 Prepaid expenses 2 Intangible assets 37,300 Goodwill 27,497 Accounts payable and accrued liabilities (2,289) Contingent consideration (2,500) Deferred revenue (1,300) Net assets acquired $ 63,883 The allocation of the purchase price paid for Get Real Health was as follows: (In thousands) Purchase Price Allocation Acquired cash $ 159 Accounts receivable 364 Prepaid expenses 107 Property and equipment 365 Operating lease asset 1,285 Intangible assets 7,890 Goodwill 9,767 Accounts payable and accrued liabilities (594) Deferred taxes, net (1,736) Operating lease liability (1,285) Contingent consideration (5,000) Deferred revenue (430) Net assets acquired $ 10,892
Pro Forma Results on Income	The following unaudited pro forma revenue, net income and earnings per share amounts for the years ended December 31, 2021 and 2020 give effect to the TruCode acquisition as if it had been completed on January 1, 2020. The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of what the operating results actually would have been during the periods presented had the TruCode acquisition been completed during the periods presented. In addition, the unaudited pro forma financial information does not purport to project future operating results. The pro forma information does not fully reflect: (1) any anticipated synergies (or costs to achieve synergies) or (2) the impact of non-recurring items directly related to the TruCode acquisition. Year Ended December 31, (In thousands, except per share data, unaudited) 2021 2020 Pro forma revenues $ 286,651 $ 275,641 Pro forma net income $ 20,635 $ 14,651 Pro forma diluted earnings per share $ 1.41 $ 1.01

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment were comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Land $ 2,848 $ 2,848 Buildings and improvements 8,269 8,242 Computer equipment 7,868 7,144 Leasehold improvements 783 1,283 Office furniture and fixtures 682 829 Automobiles 18 18 20,468 20,364 Less: accumulated depreciation (8,878) (7,225) Property and equipment, net $ 11,590 $ 13,139

Software Development (Tables)

Software Development (Tables)	12 Months Ended
	Dec. 31, 2021
Research and Development [Abstract]
Schedule of software development, net	Software development, net was comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Software development costs $ 12,693 $ 3,328 Less: accumulated amortization (1,049) (118) Software development costs, net $ 11,644 $ 3,210

Other Accrued Liabilities (Tabl

Other Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of Other Accrued Liabilities	Other accrued liabilities were comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Salaries and benefits $ 8,482 $ 7,876 Severance 236 25 Commissions 1,158 1,040 Self-insurance reserves 1,409 1,776 Contingent consideration 2,500 — Other 1,786 551 Operating lease liabilities, current portion 1,592 1,518 Other accrued liabilities $ 17,163 $ 12,786

Net Income Per Share (Tables)

Net Income Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following is a calculation of the basic and diluted EPS for the Company's common stock, including a reconciliation between net income and net income attributable to common stockholders for the years ended December 31, 2021, 2020, and 2019: (In thousands, except for per share data) 2021 2020 2019 Basic EPS Numerator Net income $ 18,430 $ 14,246 $ 20,468 Less: Net income attributable to participating securities (409) (429) (764) Net income attributable to common stockholders $ 18,021 $ 13,817 $ 19,704 Denominator Weighted average shares outstanding used in basic per common share computations 14,290 14,038 13,778 Basic EPS $ 1.26 $ 0.98 $ 1.43 Diluted EPS Numerator Net income attributable to common stockholders for diluted EPS $ 18,021 $ 13,817 $ 19,704 Denominator Weighted average shares outstanding used in basic per common share computations 14,290 14,038 13,778 Weighted average effect of dilutive securities: Performance share awards 28 — — Weighted average shares outstanding used in diluted per common share computations 14,318 14,038 13,778 Diluted EPS $ 1.26 $ 0.98 $ 1.43

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities were comprised of the following at December 31, 2021 and 2020: (In thousands) 2021 2020 Deferred tax assets: Accounts receivable and financing receivables $ 625 $ 773 Accrued vacation 678 691 Stock-based compensation 1,905 2,568 Deferred revenue 988 283 Accrued severance 44 4 Accrued liabilities 15 — Right of use asset 1,740 — Credits 2,472 3,274 Net operating loss 3,560 4,301 Deferred tax assets 12,027 11,894 Less: Valuation allowance 622 636 Total deferred tax assets $ 11,405 $ 11,258 Deferred tax liabilities: Intangible assets $ 18,002 $ 19,603 Accrued liabilities and other 4,668 956 Fixed assets 875 1077 Right of use liability $ 1,740 $ — Total deferred tax liabilities $ 25,285 $ 21,636 Total net deferred tax liability $ (13,880) $ (10,378)
Components of Income Tax Provision	Significant components of the income tax provision for the years ended December 31, 2021, 2020 and 2019 were as follows: (In thousands) 2021 2020 2019 Current provision: Federal $ 731 $ 244 $ 860 State 413 1,539 1,357 Deferred provision: Federal 3,331 2,766 951 State 171 (11) 60 Total income tax provision $ 4,646 $ 4,538 $ 3,228
Reconciliation to Federal Statutory Income Tax Rate	The difference between income taxes at the U.S. federal statutory income tax rate of 21% for the years ended December 31, 2021, 2020 and 2019, and those reported in the consolidated statements of operations for the years ended December 31, 2021, 2020 and 2019 are as follows: (In thousands) 2021 2020 2019 Income taxes at U.S. federal statutory rate $ 4,846 $ 3,945 $ 4,976 Provision-to-return adjustments 117 455 (66) State income tax, net of federal tax effect 509 908 978 Tax credits (1,274) (958) (2,196) Contingent consideration — — (1,050) Stock-based compensation (74) 255 151 Change in valuation allowance (14) (165) 173 Non-deductible compensation - 162(m) 510 — — Other 26 98 262 Total income tax provision $ 4,646 $ 4,538 $ 3,228

Stock-Based Compensation and _2

Stock-Based Compensation and Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Stock-Based Compensation Expense	The following table details total stock-based compensation expense for the years ended December 31, 2021, 2020 and 2019, included in the consolidated statements of operations: (In thousands) 2021 2020 2019 Costs of sales $ 990 $ 1,474 $ 2,040 Operating expenses 4,467 5,531 7,782 Pre-tax stock-based compensation expense 5,457 7,005 9,822 Less: income tax effect (1,146) (1,471) (2,063) Net (after tax) stock-based compensation expense $ 4,311 $ 5,534 $ 7,759
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Activity Under Restricted Stock Plans	A summary of restricted stock activity (including shares of restricted stock issued pursuant to the settlement of performance share awards) under the Plans during the years ended December 31, 2021, 2020 and 2019 is as follows: Shares Weighted-Average Grant-Date Fair Value Unvested stock outstanding at January 1, 2019 475,132 $ 32.00 Granted 133,936 30.89 Performance share awards converted to restricted stock 138,566 29.80 Vested (221,775) 33.48 Unvested stock outstanding at December 31, 2019 525,859 $ 30.51 Granted 136,771 26.16 Performance share awards converted to restricted stock 19,678 30.15 Vested (268,067) 30.80 Forfeited (1,274) 26.16 Unvested stock outstanding at December 31, 2020 412,967 $ 28.87 Granted 153,700 31.22 Vested (245,455) 29.16 Forfeited (6,329) 29.10 Unvested stock outstanding at December 31, 2021 314,883 $ 29.79
Performance shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Activity Under Restricted Stock Plans	A summary of performance share award activity under the Plans for the years ended December 31, 2021, 2020 and 2019, is as follows, based on the target award amounts set forth in the performance share award agreements: Shares Weighted-Average Grant-Date Fair Value Performance share awards outstanding at January 1, 2019 184,776 $ 30.15 Granted 110,310 30.95 Forfeited or unearned 44,189 29.77 Performance share awards converted to restricted stock (138,566) 29.80 Performance share awards outstanding at December 31, 2019 200,709 $ 30.75 Granted 107,298 26.96 Forfeited or unearned (35,477) 30.15 Performance share awards converted to restricted stock (19,678) 30.15 Performance share awards outstanding at December 31, 2020 252,852 $ 29.27 Granted 93,444 31.26 Forfeited or unearned (20,373) 29.92 Vested and issued (75,971) 30.50 Performance share awards outstanding at December 31, 2021 249,952 $ 29.59

Financing Receivables (Tables)

Financing Receivables (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Components of Short-Term Payment Plans	These receivables, included in the current portion of financing receivables, were comprised of the following on December 31, 2021 and 2020: (In thousands) 2021 2020 Short-term payment plans, gross $ 121 $ 1,973 Less: allowance for credit losses (6) (99) Short-term payment plans, net $ 115 $ 1,874
Components of Lease Receivables	The components of these receivables were as follows on December 31, 2021 and 2020: (In thousands) 2021 2020 Long-term financing arrangements, gross $ 15,659 $ 24,082 Less: allowance for credit losses (716) (1,390) Less: unearned income (1,339) (2,268) Long-term financing arrangements, net $ 13,604 $ 20,424
Sales-type and Direct Financing Leases, Lease Receivable, Maturity	Future minimum payments to be received subsequent to December 31, 2021 are as follows: (In thousands) 2022 $ 7,060 2023 4,393 2024 2,726 2025 1,309 2026 153 Thereafter 18 Total minimum payments to be received 15,659 Less: allowance for credit losses (716) Less: unearned income (1,339) Receivables, net $ 13,604
Roll-Forward of Allowance for Financing Credit Losses	The following table is a roll-forward of the allowance for financing credit losses for the years ended December 31, 2021 and 2020: (In thousands) Beginning Balance Provision Charge-offs Recoveries Ending Balance December 31, 2021 $ 1,489 $ 481 $ (1,248) $ — $ 722 December 31, 2020 $ 2,971 $ 1,632 $ (3,114) $ — $ 1,489
Analysis of Age of Financing Receivables Amounts	The following is an analysis of the age of financing receivables amounts (excluding short-term payment plans) that have been reclassified to trade accounts receivable and were past due as of December 31, 2021 and 2020: (In thousands) 1 to 90 Days Past Due 91 to 180 Days Past Due 181 + Days Past Due Total Past Due December 31, 2021 $ 713 $ 78 $ 73 $ 864 December 31, 2020 $ 1,270 $ 227 $ 672 $ 2,169
Categories of Customer Financing Receivables	The table below categorizes customer financing receivable balances (excluding short term payment plans), none of which are considered past due, based on the age of the oldest payment outstanding that has been reclassified to trade accounts receivable: (In thousands) December 31, 2021 December 31, 2020 Stratification of uninvoiced client financing receivables based on aging of related trade accounts receivable: Uninvoiced client financing receivables related to trade accounts receivable that are 1 to 90 Days Past Due $ 9,100 $ 11,719 Uninvoiced client financing receivables related to trade accounts receivable that are 91 to 180 Days Past Due 329 1,092 Uninvoiced client financing receivables related to trade accounts receivable that are 181+Days Past Due 386 2,668 Total uninvoiced client financing receivables balances of clients with a trade accounts receivable $ 9,815 $ 15,479 Total uninvoiced client financing receivables of clients with no related trade accounts receivable 4,505 6,335 Total financing receivables with contractual maturities of one year or less 121 1,973 Less: allowance for credit losses (722) (1,489) Total financing receivables $ 13,719 $ 22,298

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Definite-Lived Intangible Assets	Our purchased definite-lived intangible assets as of December 31, 2021 and 2020 are summarized as follows: December 31, 2021 (In thousands) Customer Relationships Trademark Developed Technology Total Gross carrying amount, beginning of period $ 84,370 $ 11,120 $ 29,700 $ 125,190 Intangible assets acquired 28,200 1,200 7,900 37,300 Accumulated amortization (41,738) (5,177) (20,372) (67,287) Net intangible assets as of December 31, 2021 $ 70,832 $ 7,143 $ 17,228 $ 95,203 Weighted average remaining years of useful life 9 13 8 10 December 31, 2020 (In thousands) Customer Relationships Trademark Developed Technology Total Gross carrying amount, beginning of period $ 84,370 $ 11,120 $ 29,700 $ 125,190 Accumulated amortization (33,612) (4,297) (15,592) (53,501) Net intangible assets as of December 31, 2020 $ 50,758 $ 6,823 $ 14,108 $ 71,689
Schedule of Remaining Amortization of Definite-Lived Intangible Assets	The following table represents the remaining amortization of definite-lived intangible assets as of December 31, 2021: (In thousands) For the year ended December 31, 2022 $ 14,688 2023 12,800 2024 11,266 2025 10,950 2026 10,328 Due thereafter 35,171 Total $ 95,203
Schedule of Changes in the Carrying Amount of Goodwill	The following table sets forth the change in the carrying amount of goodwill by segment for the years ended December 31, 2021, 2020, and 2019: (In thousands) Acute Care EHR Post-acute Care EHR TruBridge Total Balance as of December 31, 2018 $ 97,095 $ 29,570 $ 13,784 $ 140,449 Goodwill acquired — — 9,767 9,767 Balance as of December 31, 2019 97,095 29,570 23,551 150,216 Balance as of December 31, 2020 97,095 29,570 23,551 150,216 Goodwill acquired $ — — 27,497 27,497 Balance as of December 31, 2021 $ 97,095 $ 29,570 $ 51,048 $ 177,713

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long-term debt was comprised of the following at December 31, 2021 and 2020: (In thousands) December 31, 2021 December 31, 2020 Term loan facility $ 69,375 $ 73,125 Revolving credit facility 31,000 5,000 Debt obligations 100,375 78,125 Less: debt issuance costs (1,015) (1,308) Debt obligation, net 99,360 76,817 Less: current portion (4,394) (3,457) Long-term debt $ 94,966 $ 73,360
Schedule of Anticipated Annual Future Maturities	Anticipated annual future maturities of the term loan facility and revolving credit facility are as follows as of December 31, 2021: (In thousands) 2022 $ 4,687 2023 5,625 2024 6,563 2025 83,500 Thereafter — $ 100,375

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Supplemental Balance Sheet Information	Supplemental balance sheet information related to operating leases is as follows: (In thousands) December 31, 2021 Operating lease assets: Operating lease assets $ 7,097 Operating lease liabilities: Other accrued liabilities 1,592 Operating lease liabilities, net of current portion 5,505 Total operating lease liabilities $ 7,097 Weighted average remaining lease term in years 6 Weighted average discount rate 4.6%
Schedule of Future Minimum Lease Payments Payable Under Operating Leases	The future minimum lease payments payable under these operating leases subsequent to December 31, 2021 are as follows: (In thousands) 2022 $ 1,592 2023 1,520 2024 1,411 2025 1,202 2026 1,225 Thereafter 1,115 Total lease payments 8,065 Less imputed interest (968) Total $ 7,097

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Carrying Amounts and Fair Values of Certain Assets	The following table summarizes the carrying amount and fair value of the contingent consideration at December 31, 2021: Fair Value at December 31, 2021 Using (In thousands) Carrying Amount at 12/31/21 Quoted Price in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Description Contingent Consideration $ 2,500 $ — $ — $ 2,500 Total $ 2,500 $ — $ — $ 2,500

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The following table presents a summary of the revenues, cost of sales, and gross profit of our three operating segments for the years ended December 31, 2021, 2020, and 2019: Year Ended December 31, (In thousands) 2021 2020 2019 Revenues: Acute Care EHR Recurring revenue $ 108,440 $ 105,597 $ 109,046 Non-recurring revenue 16,939 29,173 35,028 Total Acute Care EHR revenue 125,379 134,770 144,074 Post-acute Care EHR Recurring revenue 16,472 16,272 17,466 Non-recurring revenue 1,258 1,912 3,812 Total Post-acute Care EHR revenue 17,730 18,184 21,278 TruBridge 137,520 111,534 109,282 Total revenues 280,629 264,488 274,634 Cost of sales: Acute Care EHR 65,776 64,540 68,569 Post-acute Care EHR 4,888 4,821 5,303 TruBridge 69,083 58,881 56,617 Total cost of sales 139,747 128,242 130,489 Gross profit: Acute Care EHR 59,603 70,230 75,505 Post-acute Care EHR 12,842 13,363 15,975 TruBridge 68,437 52,653 52,665 Total gross profit 140,882 136,246 144,145 Corporate operating expenses (116,175) (115,192) (119,562) Other income 1,529 1,494 807 Gain on contingent consideration — — 5,000 Loss on extinguishment of debt — (202) — Interest expense (3,160) (3,562) (6,694) Income before taxes $ 23,076 $ 18,784 $ 23,696

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	Jan. 01, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue from External Customer [Line Items]
Amortization of acquisition-related intangibles		$ 13,786,000	$ 11,421,000	$ 11,006,000
Net loss		$ (18,430,000)	$ (14,246,000)	$ (20,468,000)
Net income (loss) per share - basic (in dollars per share)		$ (1.26)	$ (0.98)	$ (1.43)
Net income (loss) per share - diluted (in dollars per share)		$ (1.26)	$ (0.98)	$ (1.43)
Goodwill impairment		$ 0	$ 0	$ 0
Product development		30,389,000	33,457,000	36,861,000
Developed Technology | Useful lives of intangible assets
Revenue from External Customer [Line Items]
Amortization of acquisition-related intangibles		1,000,000
Net loss		$ 800,000
Net income (loss) per share - basic (in dollars per share)		$ 0.06
Net income (loss) per share - diluted (in dollars per share)		$ 0.06
Software Development
Revenue from External Customer [Line Items]
Finite-lived intangible asset, useful life		5 years
Operating segments | Post-acute Care EHR
Revenue from External Customer [Line Items]
Goodwill impairment		$ 0	0	0
Impairment to purchased intangible assets		$ 0	$ 0	$ 0
Minimum
Revenue from External Customer [Line Items]
Revenue performance obligation, description of timing		3 years
Minimum | Developed Technology | As previously reported | Useful lives of intangible assets
Revenue from External Customer [Line Items]
Remaining useful life	3 years 3 months
Minimum | Developed Technology | Revision of Prior Period, Change in Accounting Principle, Adjustment | Useful lives of intangible assets
Revenue from External Customer [Line Items]
Remaining useful life	2 years
Maximum
Revenue from External Customer [Line Items]
Revenue performance obligation, description of timing		5 years
Maximum | Developed Technology | As previously reported | Useful lives of intangible assets
Revenue from External Customer [Line Items]
Remaining useful life	4 years 3 months
Maximum | Developed Technology | Revision of Prior Period, Change in Accounting Principle, Adjustment | Useful lives of intangible assets
Revenue from External Customer [Line Items]
Remaining useful life	3 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Amounts reclassified (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reclassification [Line Items]
Sales and marketing	$ 21,978	$ 22,835	$ 26,495
General and administrative	$ 50,022	47,479	45,200
As previously reported
Reclassification [Line Items]
Sales and marketing		24,185	27,774
General and administrative		46,129	43,921
Re-classifications
Reclassification [Line Items]
Sales and marketing		(1,350)	(1,279)
General and administrative		$ 1,350	$ 1,279

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Computer equipment
Property, Plant and Equipment [Line Items]
Useful life	5 years
Office furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life	5 years
Buildings
Property, Plant and Equipment [Line Items]
Useful life	30 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Changes in Deferred Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Change In Contract With Customer, Liability [Heading Roll Forward]
Beginning balance	$ 8,130	$ 8,628
Deferred revenue recorded	23,393	18,507
Deferred revenue acquired	1,300	0
Less deferred revenue recognized as revenue	(21,294)	(19,005)
Ending balance	$ 11,529	$ 8,130

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Changes in Capitalized Contract Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Change In Capitalized Contract Cost [Heading Roll Forward]
Beginning balance	$ 5,992	$ 4,439
Costs to obtain and fulfill contracts capitalized	7,256	6,974
Less costs to obtain and fulfill contracts recognized as expense	(5,936)	(5,421)
Ending balance	$ 7,312	$ 5,992

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ in Thousands	May 12, 2021	May 03, 2019	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Gain on contingent consideration			$ 0	$ 0	$ 5,000
TruCode LLC
Business Acquisition [Line Items]
Business combination, consideration transferred	$ 59,600
Contingent consideration earnout payment	$ 15,000
Acquisition related costs			900
Pro forma information, revenue			7,100
Pro forma information, pre-tax loss			$ 3,200
iNetXperts, Corp.
Business Acquisition [Line Items]
Business combination, consideration transferred		$ 10,800
Contingent consideration earnout payment		$ 14,000
Gain on contingent consideration					5,000
Acquisition related costs					$ 600

Business Combination - Prelimin

Business Combination - Preliminary allocation of the purchase price paid (Details) - USD ($) $ in Thousands	Dec. 31, 2021	May 12, 2021	Dec. 31, 2020	Dec. 31, 2019	May 03, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Goodwill	$ 177,713		$ 150,216	$ 150,216		$ 140,449
TruCode LLC
Business Acquisition [Line Items]
Acquired cash		$ 4,249
Accounts receivable		924
Prepaid expenses		2
Intangible assets		37,300
Goodwill		27,497
Accounts payable and accrued liabilities		(2,289)
Contingent consideration		(2,500)
Deferred revenue		(1,300)
Net assets acquired		$ 63,883
iNetXperts, Corp.
Business Acquisition [Line Items]
Acquired cash					$ 159
Accounts receivable					364
Prepaid expenses					107
Property and equipment					365
Operating lease asset					1,285
Intangible assets					7,890
Goodwill					9,767
Accounts payable and accrued liabilities					(594)
Deferred taxes, net					(1,736)
Operating lease liability					(1,285)
Contingent consideration					(5,000)
Deferred revenue					(430)
Net assets acquired					$ 10,892

Business Combination - Pro form

Business Combination - Pro forma information (Details) - TruCode LLC - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Pro forma revenues	$ 286,651	$ 275,641
Pro forma net income	$ 20,635	$ 14,651
Pro forma diluted earnings per share (in dollars per share)	$ 1.41	$ 1.01

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 20,468	$ 20,364
Less: accumulated depreciation	(8,878)	(7,225)
Property and equipment, net	11,590	13,139
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,848	2,848
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	8,269	8,242
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,868	7,144
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	783	1,283
Office furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	682	829
Automobiles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 18	$ 18

Software Development - Narrativ

Software Development - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)
Finite-Lived Intangible Assets [Line Items]
Capitalized software development costs	$ 8.8
Increase in capitalized software development costs	4.6
Decrease in product development costs	$ 4.6
Software Development
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	5 years

Software Development - Schedule

Software Development - Schedule of Software development costs, net (Details) (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Research and Development [Abstract]
Software development costs	$ 12,693	$ 3,328
Less: accumulated amortization	(1,049)	(118)
Software development costs, net	$ 11,644	$ 3,210

Other Accrued Liabilities (Deta

Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Salaries and benefits	$ 8,482	$ 7,876
Severance	236	25
Commissions	1,158	1,040
Self-insurance reserves	1,409	1,776
Contingent consideration	2,500	0
Other	1,786	551
Operating lease liabilities, current portion	1,592	1,518
Other accrued liabilities	$ 17,163	$ 12,786

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Numerator
Net income (loss)	$ 18,430	$ 14,246	$ 20,468
Less: Net income attributable to participating securities	(409)	(429)	(764)
Net income attributable to common stockholders	$ 18,021	$ 13,817	$ 19,704
Denominator
Weighted average shares outstanding used in basic per common share computations (in shares)	14,290	14,038	13,778
Basic EPS (in dollars per share)	$ 1.26	$ 0.98	$ 1.43
Numerator
Net income attributable to common stockholders for diluted EPS	$ 18,021	$ 13,817	$ 19,704
Denominator
Weighted average shares outstanding used in basic per common share computations (in shares)	14,290	14,038	13,778
Weighted average effect of dilutive securities:
Performance share awards (in shares)	28	0	0
Weighted average shares outstanding used in diluted per common share computations (in shares)	14,318	14,038	13,778
Diluted EPS (in dollars per share)	$ 1.26	$ 0.98	$ 1.43

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating Loss Carryforwards [Line Items]
U.S. federal statutory income tax rate	21.00%	21.00%	21.00%
Effective income tax rate	20.00%	24.00%	14.00%
Impact to effective rate			4.00%
Decrease in effective tax rate because of the provision to return adjustments	2.60%
Decrease in effective tax rate for tax shortfalls related to stock-based compensation arrangements	1.90%
Valuation allowance	$ 622	$ 636
Domestic tax authority
Operating Loss Carryforwards [Line Items]
Federal net operating loss carryforward	7,900	12,200	$ 27,900
State jurisdiction
Operating Loss Carryforwards [Line Items]
Federal net operating loss carryforward	$ 29,900	$ 34,400	$ 34,500

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Accounts receivable and financing receivables	$ 625	$ 773
Accrued vacation	678	691
Stock-based compensation	1,905	2,568
Deferred revenue	988	283
Accrued severance	44	4
Accrued liabilities	15	0
Credits	2,472	3,274
Net operating loss	3,560	4,301
Deferred tax assets	12,027	11,894
Less: Valuation allowance	622	636
Total deferred tax assets	11,405	11,258
Deferred tax liabilities:
Intangible assets	18,002	19,603
Accrued liabilities and other	4,668	956
Fixed assets	875	1,077
Total deferred tax liabilities	25,285	21,636
Total net deferred tax liability	$ (13,880)	$ (10,378)

Income Taxes - Significant Comp

Income Taxes - Significant Components of Income Tax Provision (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current provision:
Federal	$ 731	$ 244	$ 860
State	413	1,539	1,357
Deferred provision:
Federal	3,331	2,766	951
State	171	(11)	60
Total income tax provision	$ 4,646	$ 4,538	$ 3,228

Income Taxes - Reconciliation t

Income Taxes - Reconciliation to Federal Statutory Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income taxes at U.S. federal statutory rate	$ 4,846	$ 3,945	$ 4,976
Provision-to-return adjustments	117	455	(66)
State income tax, net of federal tax effect	509	908	978
Tax credits	(1,274)	(958)	(2,196)
Contingent consideration	0	0	(1,050)
Stock-based compensation	(74)	255	151
Change in valuation allowance	(14)	(165)	173
Non-deductible compensation - 162(m)	510	0	0
Other	26	98	262
Total income tax provision	$ 4,646	$ 4,538	$ 3,228

Stock-Based Compensation and _3

Stock-Based Compensation and Equity - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Sep. 04, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance (in shares)	334,629
Unrecognized compensation cost related to non-vested share-based compensation	$ 7
Unrecognized compensation cost related to non-vested share-based compensation period of recognition	1 year 10 months 24 days
Stock repurchase program, authorized amount		$ 30
Stock repurchased during period (in shares)	41,965
Stock repurchase program, remaining authorized repurchase amount	$ 28.1
Restricted stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Restricted stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Performance shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Performance shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years

Stock-Based Compensation and _4

Stock-Based Compensation and Equity - Total Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Pre-tax stock-based compensation expense	$ 5,457	$ 7,005	$ 9,822
Less: income tax effect	(1,146)	(1,471)	(2,063)
Net (after tax) stock-based compensation expense	4,311	5,534	7,759
Costs of sales
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Pre-tax stock-based compensation expense	990	1,474	2,040
Operating expenses
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Pre-tax stock-based compensation expense	$ 4,467	$ 5,531	$ 7,782

Stock-Based Compensation and _5

Stock-Based Compensation and Equity - Summary of Activity Under Restricted and Performance Stock Plans (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restricted stock
Shares
Outstanding at beginning of period (in shares)	412,967	525,859	475,132
Granted (in shares)	153,700	136,771	133,936
Performance share awards converted to restricted stock		19,678	138,566
Vested and issued (in shares)	(245,455)	(268,067)	(221,775)
Forfeited (in shares)	(6,329)	(1,274)
Outstanding at end of period (in shares)	314,883	412,967	525,859
Weighted-Average Grant-Date Fair Value
Outstanding at beginning of the period (in dollars per share)	$ 28.87	$ 30.51	$ 32
Granted (in dollars per share)	31.22	26.16	30.89
Performance share awards converted to restricted stock (in dollars per share)		30.15	29.80
Vested and issued (in dollars per share)	29.16	30.80	33.48
Forfeited (in dollars per share)	29.10	26.16
Outstanding at end of the period in dollars per share)	$ 29.79	$ 28.87	$ 30.51
Performance shares
Shares
Outstanding at beginning of period (in shares)	252,852	200,709	184,776
Granted (in shares)	93,444	107,298	110,310
Forfeited or unearned (in shares)	(20,373)	(35,477)	44,189
Performance share awards converted to restricted stock		(19,678)	(138,566)
Vested and issued (in shares)	(75,971)
Outstanding at end of period (in shares)	249,952	252,852	200,709
Weighted-Average Grant-Date Fair Value
Outstanding at beginning of the period (in dollars per share)	$ 29.27	$ 30.75	$ 30.15
Granted (in dollars per share)	31.26	26.96	30.95
Forfeited or unearned (in dollars per share)	29.92	30.15	29.77
Performance share awards converted to restricted stock (in dollars per share)		30.15	29.80
Vested and issued (in dollars per share)	30.50
Outstanding at end of the period in dollars per share)	$ 29.59	$ 29.27	$ 30.75

Financing Receivables - Narrati

Financing Receivables - Narrative (Details)	12 Months Ended
	Dec. 31, 2021
Long-Term Financing Arrangement | Minimum
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable term	2 years
Long-Term Financing Arrangement | Maximum
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable term	7 years
Short-term payment plans, gross | Minimum
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable term	3 months
Short-term payment plans, gross | Maximum
Accounts, Notes, Loans and Financing Receivable [Line Items]
Receivable term	12 months

Financing Receivables - Short-T

Financing Receivables - Short-Term Payment Plans (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Short-term payment plans, net	$ 6,488	$ 10,821
Short-term payment plans, gross
Accounts, Notes, Loans and Financing Receivable [Line Items]
Short-term payment plans, gross	121	1,973
Less: allowance for losses	(6)	(99)
Short-term payment plans, net	$ 115	$ 1,874

Financing Receivables - Compone

Financing Receivables - Components of Lease Receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Less: allowance for credit losses	$ (722)	$ (1,489)	$ (2,971)
Long-term financing arrangements, net	13,719	22,298
Long-Term Financing Arrangement
Financing Receivable, Past Due [Line Items]
Long-term financing arrangements, gross	15,659	24,082
Less: allowance for credit losses	(716)	(1,390)
Less: unearned income	(1,339)	(2,268)
Long-term financing arrangements, net	$ 13,604	$ 20,424

Financing Receivables - Future

Financing Receivables - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Less: allowance for credit losses	$ (722)	$ (1,489)	$ (2,971)
Long-term financing arrangements, net	13,719	22,298
Long-Term Financing Arrangement
Financing Receivable, Past Due [Line Items]
2022	7,060
2023	4,393
2024	2,726
2025	1,309
2026	153
Thereafter	18
Total minimum payments to be received	15,659
Less: allowance for credit losses	(716)	(1,390)
Less: unearned income	(1,339)	(2,268)
Long-term financing arrangements, net	$ 13,604	$ 20,424

Financing Receivables - Allowan

Financing Receivables - Allowance for Financing Credit Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Allowance for Doubtful Accounts Receivable [Roll Forward]
Beginning Balance	$ 1,489	$ 2,971
Provision	481	1,632
Charge-offs	(1,248)	(3,114)
Recoveries	0	0
Ending Balance	$ 722	$ 1,489

Financing Receivables - Analysi

Financing Receivables - Analysis of Age of Financing Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Total Past Due
Financing Receivable, Past Due [Line Items]
Long-term financing arrangements, gross	$ 864	$ 2,169
1 to 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Long-term financing arrangements, gross	713	1,270
91 to 180 Days Past Due
Financing Receivable, Past Due [Line Items]
Long-term financing arrangements, gross	78	227
181 + Days Past Due
Financing Receivable, Past Due [Line Items]
Long-term financing arrangements, gross	$ 73	$ 672

Financing Receivables - Summary

Financing Receivables - Summary of Financing Receivables by Credit Quality Indicator (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Total financing receivables with contractual maturities of one year or less	$ 121	$ 1,973
Less: allowance for credit losses	(722)	(1,489)	$ (2,971)
Long-term financing arrangements, net	13,719	22,298
Total Past Due
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	864	2,169
Total Past Due | Trade Accounts Receivable
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	9,815	15,479
1 to 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	713	1,270
1 to 90 Days Past Due | Trade Accounts Receivable
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	9,100	11,719
91 to 180 Days Past Due
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	78	227
91 to 180 Days Past Due | Trade Accounts Receivable
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	329	1,092
181 + Days Past Due
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	73	672
181 + Days Past Due | Trade Accounts Receivable
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	386	2,668
Financial Asset, Not Past Due
Financing Receivable, Past Due [Line Items]
Total uninvoiced client financing receivables of clients with no related trade accounts receivable	$ 4,505	$ 6,335

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		$ 125,190	$ 125,190
Intangible assets acquired	$ 37,300
Accumulated amortization	(67,287)	(53,501)
Net intangible assets	$ 95,203	71,689
Weighted average remaining years of useful life	10 years
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		84,370	84,370
Intangible assets acquired	$ 28,200
Accumulated amortization	(41,738)	(33,612)
Net intangible assets	$ 70,832	50,758
Weighted average remaining years of useful life	9 years
Trademark
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		11,120	11,120
Intangible assets acquired	$ 1,200
Accumulated amortization	(5,177)	(4,297)
Net intangible assets	$ 7,143	6,823
Weighted average remaining years of useful life	13 years
Developed Technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		29,700	$ 29,700
Intangible assets acquired	$ 7,900
Accumulated amortization	(20,372)	(15,592)
Net intangible assets	$ 17,228	$ 14,108
Weighted average remaining years of useful life	8 years

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 14,688
2023	12,800
2024	11,266
2025	10,950
2026	10,328
Due thereafter	35,171
Net intangible assets	$ 95,203	$ 71,689

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2019
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 150,216	$ 140,449
Goodwill acquired	27,497	9,767
Goodwill, ending balance	177,713	150,216
Operating segments | Acute Care EHR
Goodwill [Roll Forward]
Goodwill, beginning balance	97,095	97,095
Goodwill acquired	0	0
Goodwill, ending balance	97,095	97,095
Operating segments | Post-acute Care EHR
Goodwill [Roll Forward]
Goodwill, beginning balance	29,570	29,570
Goodwill acquired	0	0
Goodwill, ending balance	29,570	29,570
Operating segments | TruBridge
Goodwill [Roll Forward]
Goodwill, beginning balance	23,551	13,784
Goodwill acquired	27,497	9,767
Goodwill, ending balance	$ 51,048	$ 23,551

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill impairment	$ 0	$ 0	$ 0

Long-Term Debt - Schedule of De

Long-Term Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Less: debt issuance costs	$ (1,015)	$ (1,308)
Debt obligation, net	99,360	76,817
Less: current portion	(4,394)	(3,457)
Long-term debt	94,966	73,360
Line of credit
Debt Instrument [Line Items]
Debt obligations	100,375	78,125
Debt obligation, net	100,375
Line of credit | Term loan facility
Debt Instrument [Line Items]
Debt obligations	69,375	73,125
Line of credit | Revolving credit facility
Debt Instrument [Line Items]
Debt obligations	$ 31,000	$ 5,000

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) - Line of credit	Jun. 16, 2020USD ($)	Dec. 31, 2021	Jun. 30, 2022USD ($)	Jun. 30, 2024USD ($)	Mar. 31, 2025USD ($)	Jan. 31, 2016USD ($)
Debt Instrument [Line Items]
Line of credit facility, incremental facility capacity	$ 50,000,000
Minimum fixed charge coverage ratio		1.25
Maximum consolidated leverage ratio		3.5
Prepayment amount from excess cash flow		50.00%
Consolidated leverage ratio		2.5
LIBOR rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Term loan facility
Debt Instrument [Line Items]
Amount of credit facility	$ 75,000,000					$ 125,000,000
Term loan facility | Forecast
Debt Instrument [Line Items]
Quarterly principal payments			$ 900,000	$ 1,400,000	$ 1,900,000
Revolving credit facility
Debt Instrument [Line Items]
Amount of credit facility	$ 110,000,000					$ 50,000,000
Revolving credit facility | Federal funds rate
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Revolving credit facility | LIBOR rate
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Revolving credit facility | LIBOR rate | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate	1.80%
Revolving credit facility | LIBOR rate | Maximum
Debt Instrument [Line Items]
Basis spread on variable rate	3.00%
Revolving credit facility | Base rate | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate	0.80%
Revolving credit facility | Base rate | Maximum
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Amended and Restated Credit Agreement
Debt Instrument [Line Items]
Amount of credit facility	$ 185,000,000

Long-Term Debt - Anticipated An

Long-Term Debt - Anticipated Annual Future Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Debt obligation, net	$ 99,360	$ 76,817
Line of credit
Debt Instrument [Line Items]
2022	4,687
2023	5,625
2024	6,563
2025	83,500
Thereafter	0
Debt obligation, net	$ 100,375

Benefit Plans (Details)

Benefit Plans (Details) - CPSI 401(k) Retirement Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Contribution Plan Disclosure [Line Items]
Employee contribution (up to)	60.00%
Employer contribution	$ 3.2	$ 3.2	$ 2.9

Operating Leases - Supplemental

Operating Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease assets	$ 7,097	$ 6,610
Other accrued liabilities	$ 1,592	$ 1,518
Operating lease, liability, current, statement of financial position [Extensible List]	Other accrued liabilities	Other accrued liabilities
Operating lease liabilities, net of current portion	$ 5,505	$ 5,092
Total operating lease liabilities	$ 7,097
Weighted average remaining lease term in years	6 years
Weighted average discount rate	4.60%

Operating Leases - Future Minim

Operating Leases - Future Minimum Lease Payments Payable Under these Operating Leases (Details) $ in Thousands	Dec. 31, 2021USD ($)
Leases [Abstract]
2022	$ 1,592
2023	1,520
2024	1,411
2025	1,202
2026	1,225
Thereafter	1,115
Total lease payments	8,065
Less imputed interest	(968)
Operating lease liabilities	$ 7,097

Operating Leases - Narrative (D

Operating Leases - Narrative (Details) $ in Millions	Jul. 28, 2021USD ($)ft²	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Leases [Abstract]
Area of real estate property | ft²	45,000
Payments on early termination of lease	$ 0.9
Loss on termination of lease	$ 0.3
Rent expense		$ 1.8	$ 1.7	$ 2.2
Operating lease payments		$ 1.8

Fair Value (Details)

Fair Value (Details) $ in Thousands	Dec. 31, 2021USD ($)
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	$ 2,500
Total	2,500
Fair Value | Quoted Price in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	0
Total	0
Fair Value | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	0
Total	0
Fair Value | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	2,500
Total	$ 2,500

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)segment	Dec. 31, 2020USD ($)segment	Dec. 31, 2019USD ($)segment
Segment Reporting Information [Line Items]
Number of operating segments | segment	3	3	3
Sales revenues:	$ 280,629	$ 264,488	$ 274,634
Total costs of sales	139,747	128,242	130,489
Gross profit	140,882	136,246	144,145
Corporate operating expenses	(116,175)	(115,192)	(119,562)
Other income	1,529	1,494	807
Gain on contingent consideration	0	0	5,000
Loss on extinguishment of debt	0	(202)	0
Interest expense	(3,160)	(3,562)	(6,694)
Income before taxes	23,076	18,784	23,696
Operating segments | Acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:	125,379	134,770	144,074
Total costs of sales	65,776	64,540	68,569
Gross profit	59,603	70,230	75,505
Operating segments | Post-acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:	17,730	18,184	21,278
Total costs of sales	4,888	4,821	5,303
Gross profit	12,842	13,363	15,975
Operating segments | TruBridge
Segment Reporting Information [Line Items]
Sales revenues:	137,520	111,534	109,282
Total costs of sales	69,083	58,881	56,617
Gross profit	68,437	52,653	52,665
Corporate
Segment Reporting Information [Line Items]
Corporate operating expenses	(116,175)	(115,192)	(119,562)
Recurring revenue | Operating segments | Acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:	108,440	105,597	109,046
Recurring revenue | Operating segments | Post-acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:	16,472	16,272	17,466
Non-recurring revenue | Operating segments | Acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:	16,939	29,173	35,028
Non-recurring revenue | Operating segments | Post-acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:	$ 1,258	$ 1,912	$ 3,812

Subsequent Events (Details)

Subsequent Events (Details) $ in Millions	Mar. 01, 2022USD ($)
Subsequent event | Healthcare Resource Group, Inc.
Subsequent Event [Line Items]
Business combination, consideration transferred	$ 44

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts - Allowance for Doubtful Accounts (Details) - Allowance for credit losses deducted from accounts receivable in the balance sheet - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 1,701	$ 2,078	$ 2,124
Additions charged to cost and expenses	2,111	2,825	1,378
Deductions	(1,986)	(3,202)	(1,424)
Balance at end of period	$ 1,826	$ 1,701	$ 2,078

Schedule II - Valuation and Q_3

Schedule II - Valuation and Qualifying Accounts - Allowance for Credit Losses (Details) - Allowance for credit losses deducted from financing receivables in the balance sheet - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 1,489	$ 2,971	$ 2,567
Additions charged to cost and expenses	481	1,632	970
Deductions	(1,248)	(3,114)	(566)
Balance at end of period	$ 722	$ 1,489	$ 2,971